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ABSTRACT 
We have previously identified σS, an ECF sigma factor that is important in the virulence 
and stress response of S. aureus.  Transcriptional profiling of sigS revealed that it is 
differentially regulated in a variety of laboratory and clinical strains of S. aureus, 
suggesting that there exists a regulatory network that modulates its expression.  In order 
to identify direct regulators of sigS expression, we performed a biotin pull down assay in 
tandem with mass spectrometry.  We identified CymR as a direct regulator and observed 
that sigS expression is increased in cells lacking cymR. In addition, transposon 
mutagenesis was performed to identify regulators of sigS expression.  We identified 
insertions in genes that are transcriptional regulators, and elements involved in amino 
acid biosynthesis and DNA replication, recombination and repair as influencing sigS 
expression.  Finally, methyl nitro-nitrosoguanidine mutagenesis in conjunction with 
whole genome sequencing was employed and revealed mutations in the lactose repressor, 
lacR, and the membrane sensor histidine kinase, kdpD, as negatively effecting sigS 
expression.  EMSAs revealed that LacR is an indirect regulator of sigS expression, while 
the response regulator KdpE is a direct repressor.  These results indicate that a complex 
regulatory network is in place for sigS that modulates its expression.  
In a continuation of studies on σS regulation, we next explored interplay with the products 
of genes conserved within the sigS locus.  We determined that this region is conserved 
amongst all the sequenced staphylococci, and includes four genes: SAUSA300_1721 (a 
conserved hypothetical protein), as well as sigS, ecfX, and ecfY.  In order to investigate 
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the relationship between EcfX and σS we performed protein pull down assays and 
observed that these two protein interact.  Further to this, transcriptional analysis of sigS in 
an ecfX mutant reveal that expression of sigS is decreased, indicating that it is an 
activator.  Architectural analysis of the sigS locus via RNAseq revealed that the majority 
of transcription in this region comes from ecfY, a gene that is downstream and divergent 
to sigS.  We demonstrate that inactivation of ecfY leads to a significant increase in sigS 
expression, and that ecfY null strains are more resistant to DNA damaging agents such as 
UV, H2O2, MMS, and ethidium bromide, which we have previously demonstrated that a 
sigS mutant is highly sensitive to.  Our studies also revealed that an ecfY null strain is 
better able to survive intracellularly following phagocytosis by RAW 264.7 cell and 
demonstrates increased survival in whole-human blood, which is again opposed to that 
previously observed for sigS deficient strains.  Because the ecfY null strain overexpresses 
sigS, we investigated the regulon of this sigma factor using this mutant in conjunction 
with RNAseq analysis.  We identified that genes putatively under the control of σS are 
involved in DNA damage and repair, virulence, amino acid starvation and nucleic acid 
biosynthesis.  Collectively, our results indicate that σS is regulated via a unique 
mechanism: positively through an apparent need for an activator protein (EcfX) and 
negatively via RNA-RNA interaction (the 3’ UTR of ecfY).  We suggest that the 
evidence presented here greatly adds not only to our understanding of the regulatory 
circuits extant within S. aureus, but also to alternative sigma factor biology in general.  
Finally, we evaluated the efficacy of a novel library of quinazoline-based compounds 
against a highly drug resistant strain of S. aureus.  We performed structure activity and 
structure property relationship assays in order to identify lead compounds.  These 
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methods lead to the identification of N2,N4-disubstituted quinazoline-2,4-diamines that 
had low minimum inhibitory concentrations, along with favorable physiochemical 
properties.  Evaluation of their biological activity demonstrated limited potential for 
resistance of to our quinazoline based compounds, low toxicity to human epithelial cells, 
and strong efficacy in vivo.  Taken together, our findings support the use of quinazoline 
derivatives as potential new antimicrobials against multidrug resistant S. aureus. 
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CHAPTER ONE: 
INTRODUCTION 
Staphylococcus aureus.  Staphylococcus aureus, first discovered by Sir Alexander Ogston in 
1882, belongs to the bacterial family Staphylococcaceae.  S. aureus is a Gram-positive, non-
spore forming, non-motile opportunistic pathogen that can inhabit soil, water and air.  It has also 
been reported that this organism can be found colonizing nearly every surface in hospitals, day 
care centers, schools, military barracks, locker rooms and weight rooms (Begier et al., 2004; 
Hewlett, Falk, Hughes, & Mayhall, 2009; (Montgomery, Ryan, Krause, & Starkey, 2010) 
(Morrison-Rodriguez, Pacha, Patrick, & Jordan, 2010); (Oller, Province, & Curless, 2010).  S. 
aureus exists as both a commensal of human beings and a pathogen.  Indeed, approximately 50% 
of the population harbors this bacterium in their anterior nares (Frank et al., 2010).  S. aureus can 
also be found colonizing skin folds, the perineum, the axillae, and the vagina (Williams, 1963) 
(Armstrong-Esther, 1976) (Guinan et al., 1982).  Close quarter communities have an increased 
risk of infection with this organism as transmission is mediated through person-to-person contact 
and by contact with contaminated equipment (Ben-David, Mermel, & Parenteau, 2008).  S. 
aureus has the ability to infect almost any ecological niche within the human body, causing a 
wide range of diseases.  Infections caused by S. aureus typically begin as localized skin and soft 
tissue infections, such as folliculitis, furuncles, carbuncles, and impetigo.  Once this organism 
breaches the outer barrier of the body, it can then disseminate to other sites, and cause more 
severe invasive infections such as endocarditis, meningitis, osteomyelitis, and pneumonia. It can 
also cause a number of toxinoses that include food poisoning and toxic shock syndrome, which 
! 2!
are brought about through the action of individual toxins produced by the bacterium (Brook, 
2009) (Chambers, Korzeniowski, & Sande, 1983) (Goundan, Mehrotra, Mani, & Varadarajan, 
2010; Kempker, Difrancesco, Martin-Gorgojo, & Franco-Paredes, 2009) (Musher et al., 1994) 
(Sheehy et al., 2010) (Troidle, Eisen, Pacelli, & Finkelstein, 2007). 
Antibiotic Resistant S. aureus.  The success of S. aureus is due, in large part, to its rampant 
resistance to antibiotics, especially those of the β-lactam family, which includes penicillin 
(Graves, Kobayashi, & DeLeo, 2010).  Indeed, prior to the use of antibiotics, approximately 80% 
of staphylococcal blood-borne infections were fatal.  Two years after the introduction of 
penicillin, S. aureus resistance was reported (Kirby, 1945).  S. aureus circumnavigates the action 
of penicillin by using the enzyme β-lactamase, also called penicillinase.  For the β-lactam class 
of antibiotics, the bactericidal activity is due to the β-lactam ring, which binds and inhibits 
essential transpeptidase enzymes, which are responsible for catalyzing the cross-linkage of two 
peptidoglycan subunits in the final step of cell-wall biosynthesis (Wise & Park, 1965).  β-
lactamases work by cleaving the β-lactam ring, destroying the inherent antimicrobial activity 
(Sykes & Matthew, 1976). In 1959, methicillin, the first synthetic derivative of penicillin, was 
used to treat antibiotic resistant strains of S. aureus.  The presence of the ortho-
dimethyoxyphenyl side chain in this drug provides steric hindrance, which protects the β-lactam 
ring from β-lactamase activity (Simon, 1962).  In 1961, the world saw the emergence of 
methicillin-resistant Staphylococcus aureus (Klevens et al.), which is also known as multi-drug 
resistant S. aureus (Eriksen & Erichsen, 1963).  Accordingly, MRSA strains are resistant to the 
entire β-lactam family of antibiotics because of the acquisition of a genomic island that included 
a mecA gene, which encodes a transpeptidase that does not have affinity for β-lactam antibiotics 
(Hartman & Tomasz, 1984) (Hiramatsu, Cui, Kuroda, & Ito, 2001) (Reynolds & Brown, 1985) 
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(Utsui & Yokota, 1985).  In 1958, the FDA approved the use of vancomycin, a glycopeptide 
antibiotic that inhibits cell wall synthesis in bacteria. Vancomycin was not commonly used as a 
first line of defense for treating staphylococcal infection however, because it has to be 
administered intravenously, and has serious side effects associated with its use (Dutton & Elmes, 
1959).  With that said, the unwillingness to deploy vancomycin as a commonplace treatment for 
MRSA infections eroded through the 1980s and 90s as a result of it efficacy against these strains.  
Unfortunately, in 1997, reports of vancomycin intermediate S. aureus (VISA) strains began to 
appear, which, while still susceptible to the drug, required significantly higher doses to eradicate. 
In 2002 true vancomycin resistant S. aureus (VRSA) was reported in Michigan (Tenover et al., 
2004). It is believed that the genetic resistance to vancomycin was acquired via conjugation from 
the Enterococcaceae family, which are highly resistant to this drug (Livermore, 2007). 
Hospital-Acquired and Community-Acquired S. aureus.  Historically, the majority of 
infections caused by MRSA have been hospital acquired (HA-MRSA), and occur in those who 
have a history of hospitalization and immunosupression (Naimi et al., 2003).  HA-MRSA 
infections often require a longer hospital stay and more expensive treatments, as the mortality 
rates associated with them are usually very high (Klevens et al., 2007).  An increase in non-
clinical associated MRSA infections was first reported in the early 1990’s in Western Australia.  
These were caused by so-called community acquired Methicillin Resistant S. aureus (CA-
MRSA), which are seemingly more aggressive, pathologically, than HA-MRSA (Popovich, 
Weinstein, & Hota, 2008).  In 1997, CA-MRSA claimed the lives of four children in the 
Midwest United States (Klevens et al., 2007), signaling the start of a national epidemic, which 
appears to be spreading globally (Kobayashi & DeLeo, 2009).  Preceding this, in the early 
1980’s, an aggressive but isolated strain of MRSA was reported among drug users in Detroit; 
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however, these cases are not related to the CA-MRSA of the late 1990’s (Klevens et al., 2007).   
While HA-MRSA strains typically cause chronic infections, CA-MRSA strains are more 
aggressive in their pathogenesis.  The more aggressive nature of CA-MRSA strains can be 
attributed to differences in gene expression (G. Y. Cheung, Wang, Khan, Sturdevant, & Otto, 
2011).  Specifically, in CA-MRSA strains the major virulence regulator, agr, which controls the 
expression of toxins and proteases, was found to be more highly expressed in comparison to HA-
MRSA strains (G. Y. Cheung et al., 2011).  CA-MRSA is responsible for infections among 
young healthy individuals that have no predisposing complications and who commonly live in 
close quarters, such as prison-inmates, children, aboriginal populations, military personnel, 
Native Americans and athletic teams (Popovich et al., 2008).  CA-MRSA is reported to be the 
most common cause of infection seen in emergency rooms in the United States (Kobayashi & 
DeLeo, 2009), and recent studies have suggested that these strains may even be replacing 
traditional HA-MRSA strains in clinical environments (Popovich et al., 2008).  It is now 
estimated that MRSA causes more deaths annually than HIV/AIDS in the United States 
(Kobayashi & DeLeo, 2009).  Indeed, MRSA also causes more infections than Streptococcus 
pneumoniae¸ Neisseria meningitidis, and Haemophilus influenzae combined (Klevens et al., 
2007).  Furthermore, these observations are for MRSA strains, and do not consider the number of 
cases reported to be caused by methicillin sensitive S. aureus (MSSA) (Rehm & Tice, 2010).  Of 
very real concern is the observation that the number of infections caused by MSSA strains is 
estimated to be twice as many as MRSA (Rehm & Tice, 2010). 
Although, CA-MRSA strains are clinically more aggressive than HA-MRSA strains, they have 
thus far proven susceptible to non-β-lactam antibiotics (Naimi et al., 2003).  However, there have 
been recent reports of CA-MRSA that are increasingly resistance to antibiotic treatment.  In a 
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study conducted by Han et. al. CA-MRSA strains were isolated that were resistant to 
erythromycin, clindamycin, levofloxacin and tetracycline (Han et al., 2007).  Of even greater 
concern is the identification in the United States of VISA isolates from the leading community-
associated MRSA lineage, USA300 (Diep et al., 2008). 
Virulence Determinates of S. aureus.  The success of infection is dependent upon the ability of 
an organism to invade and colonize the host.  S. aureus has the unique ability invade and 
colonize almost every ecological niche of the human body.  This is mediated by the virulence 
determinants that are encoded in the S. aureus genome, and are largely distinguished by those 
associated with the cell wall/envelope, and those secreted into the extracellular milieu. 
Cell Wall Associated Virulence Determinants. In order to facilitate colonization, and therefore 
infection, S. aureus encodes a number of microbial surface components recognizing adhesive 
matrix molecules (MSCRAMMs).  MSCRAMMs are membrane-associated molecules that are 
responsible for recognizing and binding to the extracellular matrix (ECM) of the host.  The ECM 
provides structural support to the host and is made up of a variety proteins that include 
fibrinogen, collagen and fibronectin. S. aureus encodes two factors, clumping factor A (ClfA) 
and clumping factor B (ClfB), that are responsible for recognizing and binding to fibrinogen 
during early infection (McDevitt, Francois, Vaudaux, & Foster, 1994) (O'Brien, Walsh, Massey, 
Peacock, & Foster, 2002).  ClfA is the primary fibrinogen binding protein as it is expressed 
across all growth phase, whereas ClfB is expressed during early logarithmic growth (McDevitt et 
al., 1994) (Ní Eidhin et al., 1998).  In addition, S. aureus mutants lacking clfA are attenuated in 
virulence in rabbit models of endocarditis, indicating the importance of fibrinogen mediated 
adhesion (Moreillon et al., 1995). In addition to the Clf proteins, S. aureus encodes two 
fibronectin-binding proteins, FnBPA and FnBPB that bind to fibronectin (Greene et al., 1995) 
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(Jonsson, Signas, Muller, & Lindberg, 1991). Fibrinogen binding mediated by FnBPA and 
FnBPB greatly enhanced the ability of S. aureus to establish infection in a rat model of 
endocarditis (Kuypers & Proctor, 1989).  Additionally, it had previously been demonstrated that 
S. aureus can be internalized by nonprofessional phagocytes and cause persistent, chronic 
infections (Almeida, Matthews, Cifrian, Guidry, & Oliver, 1996) (Bayles et al., 1998). 
Dziewanowska et. al has demonstrated that this interaction between nonprofessional phagocytes 
and S. aureus cells is mediated through the FnBPA and FnBPB, as mutants lacking the ability to 
bind to fibrinogen were not internalized (Dziewanowska et al., 1999).  S. aureus’ ability hide 
inside nonprofessional macrophages contributes to long term colonization and thus chronic 
infections.  In order to circumvent the immune system once an infection has been established, S. 
aureus employs a number of immune evasions strategies.  One such way is through the 
production of a capsule, which is a thin polysaccharide layer that surrounds the cell.  There are 
11 different serotypes of S. aureus with regards to capsular polysaccharides, but type 5 and 8 are 
the most predominant forms (Cocchiaro et al., 2006) (Na'was et al., 1998) (Verdier et al., 2007) 
(von Eiff et al., 2007).  Capsules protect the bacterium during infection because they are resistant 
to opsonization, which is the process of the immune system marking bacteria for phagocytosis 
(van Kessel, Bestebroer, & van Strijp, 2014).  Another immune evasion strategy used by S. 
aureus is the production of surface protein A.  Surface protein A is both a surface associated and 
secreted protein that binds to the Fc region of IgG, which is the major antibody in circulation 
(Uhlen et al., 1984).  By binding to the Fc region of IgG, S. aureus inverts the antibody in the 
incorrect orientation, thus circumventing phagocytosis by professional phagocytic cells (Uhlen et 
al., 1984).  Patel et. al. demonstrated that mutants lacking spa were more easily phagocytosed by 
neutrophils, and that they are attenuated in virulence, highlighting the importance of immune 
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evasion during infection (Patel, Nowlan, Weavers, & Foster, 1987).   
Secreted Virulence Factors of S. aureus. Continuing with the theme of immune evasion, S. 
aureus secretes four bi-component toxins that are responsible for forming pores in host immune 
cells.  The Panton-Valentine Leukocidin (PVL) specifically targets neutrophils, macrophages, 
and monocytes, and contributes to virulence in rabbit models of skin infection (Lipinska et al., 
2011).  The γ-hemolysin is responsible for targeting monocytes and polynuclear leukocytes, and 
is the only leukocidin that effectively lyses red blood cells, thereby contributing to growth in 
blood, and virulence in murine models of septic arthritis (Malachowa et al., 2011) (Nilsson, 
Hartford, Foster, & Tarkowski, 1999).  Leukocidin ED (LukED) was discovered over a decade 
ago but remains the least studied of the pore-forming toxins. LukED is responsible for lysing 
polymorphonuclear (PMNs) leukocytes and it has also recently been demonstrated as 
contributing to virulence in murine models of septicemia (Alonzo et al., 2012) (Gravet et al., 
1998).  While PVL, γ-hemolysin and leukocidinED are all secreted, leukocidin AB (LukAB) is 
both secreted and associated with the cell surface (Ventura et al., 2010).  LukAB is responsible 
for lysing neutrophils, dendritic cells, macrophages and monocytes (Dumont et al., 2011), and 
contributes to the survival of S. aureus upon phagocytosis by human neutrophils (Dumont et al., 
2011).  Another virulence factor that acts to lyse immune cells is a class of secreted 
staphylococcal peptides called phenol-soluble modulins (PSM).  The S. aureus genome encodes 
two types of these amphipathic, α-helical peptides, PSMα and PSMβ, which have been shown to 
be involved in facilitating the release of S. aureus post phagocytosis and contribute to the 
pathogenesis of this organism (Otto, 2014).   
Once an infection is established and S. aureus has exhausted local nutrient sources, it employs 
toxins and proteases to facilitate tissue destruction for nutrients and dissemination to other parts 
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of the host.  Production of α-toxin is one such way for S. aureus to cause damage to host cells.  
This toxin associate as a hexamer on the surface of red blood cells and results in the formation of 
pores in the membrane, which lead to the destruction of host tissues (Bhakdi & Tranum-Jensen, 
1991).  In addition, S. aureus secretes 10 extracellular proteases that contribute to the destruction 
of host tissues.  These include six serine-like proteases (SplABCDEF), two cysteine proteases 
(ScpA and SspB), V8 serine protease (SspA), and a metalloprotease (Aur).  Recently a study was 
conducted with a strain that lacked all 10 proteases and found that this strain was hypervirulent 
and that they contribute to the stability of other secrete virulence determinants (Kolar et al., 
2013).  In addition, these extracellular proteases play a role in evading the host immune 
response. 
Regulation of Virulence Determinate Expression. S. auerus virulence determinants are 
regulated in a complex multifactorial network that includes two-component regulators, DNA-
binding proteins, regulatory RNAs and alternative σ factors.  The S. aureus quorum sensing two-
component regulatory system, agr, plays an important role in the pathogenesis of S. aureus as it 
mediates the temporal shift from expressing surface proteins to the secretion of proteases and 
toxins (Janzon, LÃ¶fdahl, & Arvidson, 1986), (Ji, Beavis, & Novick, 1995).  This switch occurs 
as the organism shifts from exponential growth to stationary phase, and is a way to overcome 
depletion of nutrients (Janzon et al., 1986), (Ji et al., 1995).  The agr system controls the 
expression of a regulatory RNA, known as RNAIII that subsequently controls the expression of 
surface proteins and exoproteins (Janzon et al., 1986), (McNamara, Milligan-Monroe, Khalili, & 
Proctor, 2000).  This regulatory RNA negatively impacts the translation of many surface 
associated proteins, such as surface protein A and coagulase, by binding to their mRNA 
transcripts directly, preventing translation and ultimately recruiting endoribonuclease III 
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(Huntzinger et al., 2005), (A. Cheung et al., 2010).  Additionally, RNAIII binds to and prevents 
the translation of Rot (repressor of toxins), which is responsible for repressing toxins and 
proteases (McNamara et al., 2000).  Another important regulator of virulence determinant 
expression is the DNA-binding protein, SarA (A. L. Cheung, Nishina, Trotonda, & Tamber, 
2008).  This global regulator brings about changes in gene expression of cell surface associated 
and secreted proteins in an agr-independent and agr-dependent manner (A. L. Cheung et al., 
2008).  In addition, sarA plays a significant role in represing extracellular proteases, whose 
activity severely limit S. aureus’ ability to form biofilms (Atwood et al., 2015). (Beenken, 
Blevins, & Smeltzer, 2003).  The S. aureus genome also encodes sixteen two-component 
systems, a number of which play a role in regulating virulence determinants.  The two-
component system SaeRS is responsible for directly controlling the expression of the 
extracellular nuclease, nuc, which was found to be important in the pathogenesis in a lung model 
of infection and in evading neutrophil extracellular traps (Van Horn et al.) (Olson et al., 2013), 
(Berends et al., 2010).  Additoinally, SaeRS is also responsible for controlling the expression of 
α-hemolysin and proteases (D. Li & Cheung, 2008), (Rogasch et al., 2006).  The two-component 
system ArlRS either directly or indirectly regulates the expression of 118 genes, which include a 
number of virulence-associated factors, such as delta-hemolysin and the major virulence 
regulator, agr (Liang et al., 2005). 
Sigma Factors.  Transcription of DNA to RNA is performed by the multisubunit enzyme RNA 
polymerase, or RNAP.  Bacterial RNAP consists of a β, β’, two identical α subunits, ω and a 
dissociable factor called the sigma factor (Gruber & Gross, 2003), (Ishihama, 2000). In addition, 
Gram-positive bacteria encode two other accessory subunits, ε and δ (Burgess, 1969), (Keller et 
al., 2014), (Pero, Nelson, & Fox, 1975).  Sigma factors play a central role in promoter 
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recognition and promoter melting, without them there would be no transcription.  Sigma factors 
belong to two large, unrelated protein families, σ70 and σ54 (Helmann & Chamberlin, 1988).  The 
σ54 family of sigma factors has mainly been associated with nitrogen utilization, however it is 
also involved in dicarboxylic acid transport, toluene and xylene catabolism, hydrogenase 
biosynthesis and pilus production (Merrick, 1993).  This family of sigma factors is relatively 
widespread, although not ubiquitous, as none having been identified in high G-C Gram-positive 
bacteria or cyanobacteria  (Gruber & Gross, 2003), (Patek & Nesvera, 2011), (Sachdeva, Misra, 
Tyagi, & Singh, 2010), (Wosten, 1998).  For those species that encode σ54 sigma factors, there 
usually exists one copy, with the exception of Bradyrhizobium japonicum, Rhodobacter 
sphaeroides, and Rhizobium etli, which encode two  (Choudhary, Mackenzie, Mouncey, & 
Kaplan, 1999), (Kullik et al., 1991), (Michiels, Moris, Dombrecht, Verreth, & Vanderleyden, 
1998).  Unlike the σ70 family of sigma factors, which can associate with RNAP and initiate 
transcription without additional proteins, the σ54 family cannot initiate open complex formation 
without the presence of an activator protein, which binds anywhere from 100 to 1000 nucleotides 
upstream of target promoters  (Buck, Miller, Drummond, & Dixon, 1986), (Reitzer & 
Magasanik, 1986).   
The σ70 family is the major class of σ factors and are typically characterized by 4 general 
domains (Figure 1), however only two are essential for activity (regions 2 and 4), and are 
absolutely conserved across all members  (M. Lonetto, Gribskov, & Gross, 1992), (Wosten, 
1998).  Region 1 prevents the σ factor from binding indiscriminately to DNA without RNAP, 
and is thus considered inhibitory to  
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Figure 1.  Schematic representation of the four domains of the σ70 subfamily of sigma 
factors. Region σ1 is responsible for inhibiting sigma factor binding to promoter regions in the 
absence of RNAP.  Region σ3 interacts with DNA upstream of the -10 consensus sequence at so-
called extended -10 sites.  Regions σ2 and σ4 are the most highly conserved and are responsible 
for recognizing the -10 and -35 consensus sequences, respectively.
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function  (Helmann & Chamberlin, 1988).  Region 2 can be further broken down into 4 sub-
regions that collectively facilitate promoter melting:  Regions 2.1 and 2.2 are required for 
binding to core-RNAP, region 2.3 is responsible for promoter melting, and region 2.4 directly 
interacts with the -10 consensus sequence of the promoter (Aiyar, Juang, Helmann, & deHaseth, 
1994), (Joo, Ng, & Calendar, 1997), (Shuler, Tatti, Wade, & Moran, 1995), (Tatti, Shuler, & 
Moran, 1995).  Region 3 of σ70 factors interacts with DNA upstream of the -10 consensus 
sequence at so-called extended -10 regions (Helmann & Chamberlin, 1988).  Region 4 contains a 
helix turn helix (HTH) domain that is responsible for recognition of the -35 consensus sequence, 
and is also responsible for interacting with the β-subunit to result in HTH association with the -
35 consensus sequence (Campbell et al., 2002), (Helmann & Chamberlin, 1988), (Murakami & 
Darst, 2003).  The σ70 family can be broken down into 5 different groups (Table 1):  Group 1 
sigma factors are the primary sigma factors (Helmann, 2002), which are control the majority of 
transcription in rapidly growing bacterial cells, and are essential, with the exception of 
Chlorobium tepidum (Kill et al., 2005).  Interestingly, in this particular bacterium there is a 
frame shift mutation in the gene encoding the housekeeping sigma factor, which leads to a 
truncated protein.  It is unclear as to how C. tepidum survives without a primary sigma factor to 
direct transcription; however, it can be hypothesized that there exist alternative sigma factors that 
direct the transcription of housekeeping genes.  Group 2 are nonessential paralogs of group 1, 
which, as with group 1, also contain all four of the conserved sequence regions.  In addition, 
there is likely overlap in promoter recognition between group 1 and 2 sigma factors because the 
regions that determine promoter selectivity are nearly identical (Helmann, 2002).   Group 3 
sigma factors can be further divided into three evolutionarily related clusters; a heat shock 
cluster, a flagellar biosynthesis cluster, and a sporulation cluster (Helmann, 2002).  Group 4    
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Table 1.  Subfamilies of σ70 sigma factors. 
Group Function Examples 
1 Primary or Housekeeping sigma factors.  They 
are responsible for a majority of transcription in 
the cell. 
σA of B. subtilis; σ70 of E. coli 
2 Nonessential homologs of primary sigma factors σD of S. coelicolor; σS of E. coli 
3 Secondary sigma factors σ28 of S. coelicolor; σ28 of S. 
typhimurium 
4 Extracytoplasmic function (ECF) sigma factors  σE of S. coelicolor; σE of E. coli 
5 TxeR subfamily; Regulate toxin production TxeR of C. difficile  
 
  
! 14!
sigma factors are known as extracytoplasmic function (ECF) sigma factors and typically respond 
to environmental stress (M. Lonetto et al., 1992).  This group is the most structurally diverse in 
that it lacks both regions 1 and 3 (Helmann, 2002), (M. Lonetto et al., 1992).  Group 5 sigma 
factors were identified in 2001 in Clostridium difficile and are commonly involved in the 
regulation of toxin production (Helmann, 2002), (Mani, 2001). 
Extracytoplasmic Function (ECF) Sigma Factors.  There were two separate lines of 
investigation that led to the discovery of the ECF subfamily of sigma factors.  Work by the 
Buttner group identified sigE of Streptomyces coelicolor, describing it as having only distant 
similarity to other known sigma factors (Helmann, 2002).  In 1994, Lonetto et al. characterized 
σE of S. coelicolor and noted that there was a high degree of similarity to σE of Escherichia coli, 
AlgU of Pseudomonas aeruginosa, CarQ of Myxococcus xanthus, FecI of E. coli, HrpL of P. 
syringae, CnrH of Alcaigenes eutrophus and SigX of Bacillus subtilis; suggesting that these 
transcription factors make up a subfamily of sigma factors that respond to extracytoplasmic 
stimuli (M. A. Lonetto, Brown, Rudd, & Buttner, 1994).  Since their discovery, it has been 
observed that ECF sigma factors are the largest subfamily of sigma factors with an average of six 
such elements present per bacterial genome (Staron et al., 2009).  Indeed, ECF sigma factors 
outnumber in representatives all other subfamilies of sigma factors combined.  As a general 
trend, the amount of ECF sigma factors per bacterial genome increase with genome size and the 
complexity of an organism’s lifestyle.  While ECF sigma factors are restricted to prokaryotes, 
they are often described as ubiquitously distributed in bacterial species, although none have been 
identified in any of the currently sequenced genomes of the Aquificae, Chlamydiae, Rikettsiales 
phyla, or the genera of Borrelia and Mycoplasma, all of which are either obligate symbionts or 
pathogens with genomes that are less than 2 million base pairs (Staron et al., 2009).  The phyla 
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with the most ECF sigma factors are Acidobacteria, Actinobacteria and Bacteroidetes with an 
average of 40-50 per genome (Staron et al., 2009).  Notably, however, the δ-proteobacteria, 
Sorangium cellulosum, has 83 identified ECF sigma factors; although this is perhaps 
unsurprising as this bacterium also has the largest prokaryotic genome identified to date, with 
over 13 million base pairs (Schneiker et al., 2007). 
As described above, the σ70 family of sigma factors is structurally characterized as having four 
distinct regions that are responsible for bringing about transcription (Helmann, 2002), (M. 
Lonetto et al., 1992), (Wosten, 1998).  However, ECF sigma factors are unique in that they only 
contain the most conserved regions, 2 and 4 (Helmann, 2002).   Typically, ECF sigma factors are 
characterized by three common hallmarks: The first is that they usually recognize an AAC motif 
and a grouping of CGTs in the -35 and -10 consensus sequences of promoter regions, 
respectively (Helmann, 2002), (Lane & Darst, 2006).  Secondly, it is not uncommon to find ECF 
sigma factors transcriptionally linked to a cognate transmembrane anti-sigma factor, which acts 
as an antagonist to the sigma factor by sequestering it and preventing it from initiating 
transcription (Helmann, 1999).  Lastly, ECF sigma factors control the transcription of genes that 
are involved in transport, or in responding to stress caused to the cell envelope (Helmann, 2002), 
(M. Lonetto et al., 1992).  While these characteristics have held true for ECF sigma factors over 
the last decade, we are now beginning to see a shift in the ECF paradigm, whereby, as more are 
discovered, we observe that they are often flanked by conserved genes that could indicate a novel 
mechanism of regulation distinct from the anti-sigma factor partner switching mechanism. An 
example of this comes from sigJ in M. tuberculosis, which is flanked by oxidoreductases genes 
that are hypothesized to be involved in regulating this sigma factor by an unknown mechanism 
(Staron et al., 2009), (Hu, Kendall, Stoker, & Coates, 2004). In addition, as the number of ECF 
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sigma factors identified grows, it becomes apparent that there also exist a subset of ECF sigma 
factors that are responsible for sensing and responding to cytoplasmic stress, as indicated by the 
presence of soluble anti-sigma factors (Dufour, Landick, & Donohue, 2008), (Gunesekere et al., 
2006), (Mark S. B. Paget & Helmann, 2003), (Ward, Lew, Treuner-Lange, & Zusman, 1998), 
(Wu, Kong, Lam, & Husson, 1997). 
Role of ECF Sigma Factors in Cell Physiology.  With the number of ECF sigma factors 
growing each year, it is now thought that they represent one of the top three signal transduction 
mechanisms in bacterial genomes, behind one and two component systems (Staron et al., 2009).  
This stands to reason because the use of alternative sigma factors represents an efficient and 
powerful way to change gene expression as they are typically transcribed and translated, but held 
inactive by cognate anti-sigma factors until an appropriate stress is detected (Helmann, 2002), 
(M. Lonetto et al., 1992).  Historically, ECF sigma factors have been known to function in 
controlling the expression of genes involved in responding to environmental stress, such as, but 
not limited to, oxidizing agents, antimicrobial peptides, heat shock, iron stress and nutrient 
limitation.  One of the most well characterized ECF sigma factors is σE of E. coli.  In E. coli, σE 
is responsible for the transcription of 40 genes that are involved in maintaining the integrity of 
the cell envelop in response to periplasmic stress, such as improperly folded proteins (De Las 
Penas, Connolly, & Gross, 1997), (Erickson & Gross, 1989), (Missiakas, Mayer, Lemaire, 
Georgopoulos, & Raina, 1997), (Wang & Kaguni, 1989).  In addition to being involved in 
maintaining cell envelope integrity, σE is also involved in the heat shock response by controlling 
transcription of the P3 promoter of rpoH (Erickson & Gross, 1989), (Missiakas et al., 1997), 
(Wang & Kaguni, 1989).  The rpoH gene encodes the heat shock sigma factor, σ32, which 
controls the expression of genes involved in combating elevated temperatures (Grossman, 
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Erickson, & Gross, 1984).  In addition to being one of the most well characterized ECF sigma 
factors, σE is also one of the most well conserved, as homologs have been identified in S. 
coelicolor, Salmonella typhimurium, Mycobacteria tuberculosis, Haemophilus influenza and 
Psuedomonas aeruginosa, (Craig, Nobbs, & High, 2002), (Humphreys, Stevenson, Bacon, 
Weinhardt, & Roberts, 1999), (M. Lonetto et al., 1992), (Martin, Holloway, & Deretic, 1993), 
(R. Manganelli, Dubnau, Tyagi, Kramer, & Smith, 1999; R. Manganelli, Voskuil, Schoolnik, & 
Smith, 2001). 
In S. coelicolor, σE is also involved in maintaining the integrity of the cell envelope (Hutchings, 
Hong, Leibovitz, Sutcliffe, & Buttner, 2006), however, unlike in E. coli, σE in S. coelicolor is 
also active in maintaining cell envelope integrity under standard conditions (Hutchings et al., 
2006).  In S. typhimurium, σE is not required for survival of the pathogen at elevated 
temperatures (Humphreys et al., 1999), however mutants lacking this element are less able to 
survive than the parental strain when grown in the presence of alternative carbon sources, and 
when exposed to oxidizing agents (such as hydrogen peroxide and superoxide) and antimicrobial 
peptides (Humphreys et al., 1999).  σE is also one of the ten ECF sigma factors encoded within 
the genome of M. tuberculosis, and is the best characterized of these transcription factors.  Like 
E. coli, σE in M. tuberculosis is involved in the response to heat shock (R. Manganelli et al., 
1999; R. Manganelli et al., 2001), but is also important in the cells response to vancomycin, 
oxidative stress, and the detergent sodium dodecyl sulfate (SDS) (R. Manganelli et al., 2001).  
The σE encoding gene is also highly conserved in other species of Mycobacterium, such as M. 
smegmatis, M. bovis, M. leprae, M. avium, and M. fortuitum, where it has been experimentally 
demonstrated to be involved in the response to acid shock, heat shock, oxidative stress, and 
detergents (Wu et al., 1997).  While there has been very little research into the role that σE has in 
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the life-style of H. influenzae, it has been demonstrated that this ECF sigma factor is important 
for intracellular survival in murine derived macrophages, indicating its importance during the 
pathogenesis of this organism (Craig et al., 2002).  AlgU, the σE homolog in P. aeruginosa, is 
involved in alginate biosynthesis, oxidative stress, heat shock, osmotic stress, cell wall stress and 
immune evasion (Aspedon, Palmer, & Whiteley, 2006), (Firoved & Deretic, 2003), (Potvin, 
Sanschagrin, & Levesque, 2008), (Wood, Leech, & Ohman, 2006; Wood & Ohman, 2009).  
More recent studies have demonstrated that AlgU is also important in the ability of the 
nonmucoid form of P. aeruginosa to form biofilms (Bazire et al., 2010).  In addition, P. 
aeruginosa mutants lacking algU demonstrate a decrease in motility, which is an important 
function in colonization of the lungs (Bazire et al., 2010).  However, these decreases in biofilm 
formation and motility are not a result of direct control of AlgU on key biofilm and motility 
genes, but control of their regulators instead  (Bazire et al., 2010).   
One of the earliest discovered and most well understood ECF sigma factors is CarQ of the Gram-
negative organism Myxococcus xanthus.  CarQ is one of approximately 45 ECF sigma factors in 
the M. xanthus genome and is responsible for carotenoid biosynthesis (Galbis-Martinez, Galbis-
Martinez, Murillo, & Fontes, 2008).  Carotenoids are pigments that are made in response to light 
and these compounds protect the organism from reactive oxygen species (ROS) produced by 
light.  The Bacillus subtilis genome encodes seven ECF sigma factors, with σW and σM being two 
of the best characterized in Gram-positive bacteria.  It has been demonstrated that σW controls the 
expression of a large regulon that is made up of genes required for maintaining cell wall stability, 
especially following exposure to cell wall targeting antibiotics (Butcher & Helmann, 2006), (Cao 
et al., 2002), (Cao, Moore, & Helmann, 2005).  In addition, there is evidence to suggest that σW 
controls the expression of genes that are involved in the biosynthesis and secretion of 
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bacteriocins (Butcher & Helmann, 2006), (Cao et al., 2002).  The ECF sigma factor σM of B. 
subtilis has been shown to be involved in responding to cell wall targeting antibiotics, which 
include vancomycin, phosphomycin, and bacitracin, heat shock, acid shock, ethanol exposure, 
oxidative stress, and osmotic pressure (Cao et al., 2002).  B. subtilis also encodes a number of 
other ECF-sigma factors, including  σV. In regards to this element, although it is not well 
characterized, it has been shown to be involved in the response to lysozyme (Guariglia-Oropeza 
& Helmann, 2011) . Indeed, it is thought that σV is the major ECF sigma factor responsible for 
sensing and responding to lysozyme stress in B. subtilis, as a sigV mutant and a mutant lacking 
all seven ECF sigma factors demonstrated the same sensitivity to lysozyme (Guariglia-Oropeza 
& Helmann, 2011), (Ho, Hastie, Intile, & Ellermeier, 2011).  While the regulon of this ECF 
sigma factor remains unclear, it is hypothesized that the resistance to lysozyme is mediated 
through σV dependent control of genes that are involved in cell wall biosynthesis, such as oatA, a 
peptidoglycan O-acytal transferase, the dltABCDE operon, which encodes enzymes that are 
involved in teichoic acid D-alanylation; and pbpX a transpeptidase (Guariglia-Oropeza & 
Helmann, 2011), (Ho et al., 2011).  Indeed, in the Gram-positive nosocomial pathogen 
Enterococcus faecalis, σV, the only identified ECF sigma factor in this organism to date, was 
also found to contribute to resistance to lysozyme (Ahmed et al., 2010); however, it does not 
appear to be through σV mediated control of oat or the dltABCDE operon (Ahmed et al., 2010).  
In addition to contributing to the resistance of E. faecalis to lysozyme, σV is also responsible for 
contributing to survival following heat shock, acid shock, and treatment with ethanol (Benachour 
et al., 2005). The non-pathogenic, high G+C Gram-positive organism Corynebacterium 
glutamicum encodes five ECF sigma factors, with the best characterized being σH .  In this 
organism, σH is responsible for sensing and responding to heat and oxidative stress, and either 
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directly or indirectly controls the expression of 65 genes, including four alternative sigma factors 
and a number of stress response regulators (Patek & Nesvera, 2011).  
ECF Sigma Factors and their Role in Pathogenesis.  In addition to the growing number of 
ECF sigma factors, their role in virulence is become increasingly apparent.  The role of ECF 
sigma factors in virulence The highly conserved ECF sigma factor σE is not only important in 
bacterial physiology but also in its ability to facilitate infection. In uropathogenic E. coli, degS 
encodes an inner membrane protease that is responsible for cleaving the anti-σE factor, RseA.  
Mutants lacking the gene degS were attenuated in its ability to cause infection in a murine model 
of urinary tract infection, suggesting the importance of σE in the virulence response of 
uropathogenic E. coli (Redford, Roesch, & Welch, 2003; Redford & Welch, 2006).  In addition, 
the ability of S. typhimurium to cause infection is also dependent upon the ECF sigma factor σE.  
Humphreys et. al. demonstrated that cells lacking σE were attenuated in virulence using a murine 
model of infection (Humphreys et al., 1999).  In addition, without σE, cells are less able to 
survive within human derived macrophages and epithelial cells post phagocytosis, when 
compared to the wild-type S. typhimurium strain (Humphreys et al., 1999).  The M. tuberculosis 
genome encodes ten ECF sigma factors, seven of which are either involved in, or predicted to be 
involved in, virulence, with the most important being σE. Indeed, several studies have 
demonstrated that the pathogenesis of M. tuberculosis is depended upon σE. (Abdul-Majid et al., 
2008), (Agarwal, Woolwine, Tyagi, & Bishai, 2007), (Ando, Yoshimatsu, Ko, Converse, & 
Bishai, 2003), (Calamita et al., 2005), (Cardona et al., 2012), (Graham & Clark-Curtiss, 1999), 
(Karls, Guarner, McMurray, Birkness, & Quinn, 2006), (Kaushal et al., 2002), (Riccardo 
Manganelli & Provvedi, 2009; R. Manganelli et al., 2001), (S. Park & Imlay, 2003), (Raman et 
al., 2006; Raman et al., 2001), (Sun et al., 2004).  Schnappinger et. al. compared the 
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transcriptomes of M. tuberculosis grown under standard laboratory conditions and to those 
isolated from murine macrophages after phagocytosis, and revealed that transcription of the ECF 
sigma factor σE was among the first genes to be upregulated (Schnappinger et al., 2003).  In 
addition, it has also been previously described that expression of σE is strongly induced upon 
phagocytosis by human macrophages, suggesting a role in virulence (Graham & Clark-Curtiss, 
1999; R. Manganelli et al., 2004).  Further to this, a number of studies have demonstrated that a 
sigE null strain (the gene that encodes σE) of M. tuberculosis was not able to survive after 
phagocytosis by THP-1 derived macrophages, murine-like macrophages, and monocyte derived 
dendritic cells ((Casonato, Provvedi, Dainese, Palu, & Manganelli, 2014; Giacomini et al., 2006) 
(R. Manganelli et al., 2001).  Additionally, Ando et. al. and Manganelli et. al. demonstrated in a 
murine model of lung infection, a sigE null strain was significantly attenuated in virulence when 
compared to the wild-type (Ando et al., 2003), (R. Manganelli et al., 2004). Strikingly, several 
studies have documented that a live attenuated vaccine made with an inactivated sigE, either by 
insertion of an antibiotic resistance cassette, or deletion, led to better immunogenicity than the 
current available BCG vaccine derived from M. bovis (Casonato et al., 2014), Hernandez 
(Hernandez Pando, Aguilar, Smith, & Manganelli, 2010).  Another ECF sigma factor in M. 
tuberculosis that has been shown to be important in virulence is σC. Sun et. al. has been 
demonstrated that the lethality of M. tuberculosis is also dependent on the ECF sigma factor σC 
in a macrophage model of tuberculosis (Sun et al., 2004).  Further to this, Sun et. al. also 
performed a microarray to determine the regulon of  σC   and found that the expression of 
virulence determinants are decreased in a sigC null strain, which would explain the attenuation in 
virulence demonstrated in a macrophage model of tuberculosis (Sun et al., 2004).  In P. 
aeruginosa, AlgU, is also important in pathogenesis, especially in cystic fibrosis (McFarland & 
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Stocker) patients (Govan & Harris, 1986), (Ogle, Janda, Woods, & Vasil, 1987). AlgU is 
responsible for controlling production of alginate, which is the mucoid covering that protects this 
bacterium in the lungs, and helps mediate infection (Govan & Harris, 1986), (Ogle et al., 1987) 
by preventing phagocytosis and facilitating adherence (Marcus & Baker, 1985), (Ramphal & 
Pier, 1985), (Schwarzmann & Boring, 1971),.  In addition, it has also been demonstrated that 
ECF sigma factors play a significant role in the uptake of iron, so much so that they form a 
subgroup of ECF sigma factors known as iron starvation (IS) ECF sigma factors (Leoni, Ciervo, 
Orsi, & Visca, 1996), (Visca, Leoni, Wilson, & Lamont, 2002).  This is highlighted in P. 
aeruginosa by the fact that of the 20 hypothesized ECF sigma factors encoded in the genome, 14 
are thought to be involved in siderophore uptake (Banin, Vasil, & Greenberg, 2005), (Beare, For, 
Martin, & Lamont, 2003), (Leoni, Orsi, de Lorenzo, & Visca, 2000), (Llamas et al., 2008; 
Llamas et al., 2006), (Ochsner, Johnson, Lamont, Cunliffe, & Vasil, 1996), (Visca, Imperi, & 
Lamont, 2007).  It is well documented that the production of many P. aeruginosa virulence 
factors is controlled by the concentration of iron available in the environment.  One of the most 
well studied ECF sigma factor involved in iron uptake is PvdS.  This IS ECF sigma factor is 
considered the main iron starvation sigma factor of P. aeruginosa, as it controls the expression of 
genes involved in biosynthesis of pyroverdine, the primary siderophore, and its cognate receptor, 
PvdA (Cunliffe, Merriman, & Lamont, 1995).  Mutants lacking pvdS are known to be attenuated 
in a rabbit model of infection, and are less able to form a biofilm than parental strains (Banin et 
al., 2005), (Hunt, Peng, Loubens, & Storey, 2002), (Visca et al., 2007), (Xiong, Vasil, Johnson, 
Ochsner, & Bayer, 2000).  This attenuation of virulence has been linked to PvdS mediated-
control of transcription for at least 26 operons or genes (Cunliffe et al., 1995), (Ochsner et al., 
1996; Ochsner, Wilderman, Vasil, & Vasil, 2002), (Shigematsu et al., 2001). 
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The information available on the role of ECF sigma factors in the pathogenesis of Gram-positive 
bacteria is very limited, but is an area of growing interest.  The genome of C. diptheriae, the 
causative agent of diphtheria, harbors two ECF sigma factors, σE and σH.  Diphtheria is a disease 
that is as result of the production of a toxin (DT), which is under the control of an iron dependent 
regulator, DtxR (Boyd, Oza, & Murphy, 1990).  There is bioinformatics evidence to suggest that 
expression of this major regulator is controlled by both σE and σH Oram, as promoter elements 
that are characteristic of σE and σH from the closely related bacterium M. tuberculosis are located 
upstream of dtxR. Accordingly, this suggests that these two sigma factors may contribute to the 
pathogenesis of C. diphtheriae (Oram, Jacobson, & Holmes, 2006).  Further to this, the Gram-
positive Firmicute Clostridium difficile encodes three ECF sigma factors CsfT, CsfU and CsfV, 
all of which are thought to be involved in virulence (Ho & Ellermeier, 2011).  Ho et. al. has 
recently described that the inactivation of a proteases involved in the regulatory cascade leading 
to CsfT, CsfU and CsfV upregulation renders this bacterium unable to colonize intestines in a 
hamster model of infection (Ho & Ellermeier, 2011).  Ahmed et. al. demonstrated in a murine 
model of sepsis and a murine model of urinary tract infection that significantly less sigV mutant 
was recovered from the organs when compared the wild-type, thus indicating σV plays a role in 
the pathogenesis of E. faecalis (Ahmed et al., 2010).  It is not, however, known exactly how σV 
contributes to the virulence of E. faecalis as its regulon, and thus mechanistic role within the cell, 
has yet to be elucidated (Ahmed et al., 2010). 
Regulation of ECF Sigma Factors.  ECF sigma factors are responsible for controlling the 
expression of small regulons that are involved in responding to a particular environmental stress.  
When bacterial cells are not experiencing stress, there must exist a mechanism of regulating 
sigma factor activity so as to prevent transcription of unnecessary genes.  Historically, a hallmark 
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of the ECF sigma factor subfamily is that they are controlled by cognate anti-sigma factors that 
are co-transcribed with the sigma factor (Helmann, 2002), (Staron et al., 2009).  Anti-sigma 
factors are usually membrane associated proteins consisting of at least one transmembrane 
spanning region and interact with the ECF sigma factor through a conserved N-terminal domain, 
while the C-terminal domain is located in the extracellular space sensing the environmental 
surroundings (Helmann, 1999), (Hughes & Mathee, 1998), (Staron et al., 2009).  ECF sigma 
factor regulation by anti-sigma factors has been well studied regarding many σE homologues.  
For example, σE of E. coli is regulated by its cognate anti-sigma factor RseA, both of which are 
encoded within the same operon, along with two other genes (rseBC) that are involved in 
regulating σE (Missiakas et al., 1997).  RseA is an inner membrane protein whose N terminal 
region interacts with σE, while the C terminal domain is located in the periplasm where it 
interacts with RseB (Missiakas et al., 1997).  It is hypothesized that RseB may sense misfolded 
proteins and transmit this signal to RseA, leading to a conformation change and the release of σE 
(Missiakas et al., 1997).  In the context of RseC, it is thought to regulate via anti-anti-sigma 
factor activity also, as it has been demonstrated that in the absence of rseC there is an 
overexpression of σE (Missiakas et al., 1997). 
The σE homologue in P. aeuriginosa, AlgU is also regulated by an anti-sigma facotor.  AlgU is 
the first gene in a five-gene operon that includes mucABCD, which are hypothesized to be 
responsible for regulating the activity of AglU (Ramsey & Wozniak, 2005).  The mucA gene 
encodes the anti-sigma factor that is responsible for binding to AlgU and sequestering it (Ramsey 
& Wozniak, 2005).  Similar to RseB in E. coli, MucB is located in the periplasm and interacts 
with the C terminal region of MucA, thereby negatively regulating AlgU activity (Rowen & 
Deretic, 2000).  While, the precise role of MucC has yet to be elucidated, there is evidence to 
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suggest that it may interact with either MucA or MucB to negatively regulate AlgU. (Rowen & 
Deretic, 2000).  Finally, MucD is a homolog of DegS, and therefore may be involved in the 
cleavage of the anti-sigma MucA (Rowen & Deretic, 2000).  In CF patients, it is the 
disregulation of alginate biosynthesis that leads to the overproduction of the exopolysaccharide, 
alginate (Damron & Goldberg, 2012), (Pulcrano, Iula, Raia, Rossano, & Catania, 2012).  In P. 
aeruginosa strains that colonize the lungs of CF patients, this environment leads to the 
accumulation of point mutations in the genome.  When these mutations occur in the mucA gene, 
this leads to a non-functional MucA that cannot sequester AlgU, leaving AlgU to overexpress the 
genes involved in biosynthesis of alginate (Damron & Goldberg, 2012), (Pulcrano et al., 2012).  
In CF patients, alginate is considered a virulence factor as this mucoid layer results in an 
inability of the host immune system to clear the infection.  In addition, alginate overproduction 
has also been linked to an increase in drug resistance because of the inability of drugs to 
penetrate the thick mucoid layer (Pedersen, Hoiby, Espersen, & Koch, 1992). 
With the continued characterization of ECF-sigma factors, and their cognate anti-sigma factors, 
it is becoming increasingly apparent that the latter are not always transmembrane proteins.  The 
ECF sigma factor, σR of S. coelicolor is responsible for responding to oxidative stress in the 
cytoplasm of this bacterium (M. S. B. Paget, 1998).  σR is regulated by its anti-sigma factor 
RsrA, which is a cytoplasmic protein, and, upon oxidative stress, will undergo a conformational 
change that results in the release of σR (Bae, Park, Hahn, Kim, & Roe, 2004), (W. Li et al., 2003; 
W. Li et al., 2002), (M. S. Paget et al., 2001), (Zdanowski et al., 2006).  This conformational 
change is mediated by the formation of intra-molecular disulfide bond formations that prevents 
RsrA from binding and inhibiting the activity of σR (Kang et al., 1999).  In addition, the σE 
homolog of the photosynthetic bacteria Rhodobacter sphaeroides is responsible for responding 
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to heme stress and blue light, which can lead to DNA damage (Braatsch, Moskvin, Klug, & 
Gomelsky, 2004), (Newman, Falkowski, Schilke, Anthony, & Donohue, 1999).  This sigma 
factor is regulated by a soluble anti-sigma factor, ChrR (Newman et al., 1999).  The exact 
mechanism of σE-ChrR interaction is largely unknown; however, it has previously been 
demonstrated that they form a heterodimer, and that ChrR requires zinc in order to inhibit σE 
(Newman et al., 1999). 
Recent research suggests that ECF sigma factors are not regulated by anti-sigma factors alone, 
but that multiple mechanisms of controlling sigma factor activity exists. The ECF sigma factor 
PvdS is regulated by the anti-sigma factor FpvR, but is also regulated at the level of transcription 
by the iron regulator Fur (Leoni et al., 1996; Leoni et al., 2000),.  In addition, CysB, which is the 
master regulator of sulfur metabolism in P. aeruginosa, also controls expression of pvdS (Imperi, 
Tiburzi, Fimia, & Visca, 2010).  The Fur repressor is also involved in regulating the IS ECF 
sigma factor PbrA of P. fluorescence, PfrI and PupI of P. putida and FecI of E. coli (Angerer, 
Enz, Ochs, & Braun, 1995), (Koster, van Klompenburg, Bitter, Leong, & Weisbeek, 1994), 
(Venturi, Ottevanger, Leong, & Weisbeek, 1993).  Interestingly, there also exist ECF sigma 
factors that are not regulated by anti-sigma factors at all.  The first sigma factor to be classified 
as an ECF sigma factor, σE of S. coelicolor, is not regulated at the post-translational level by an 
anti-sigma factor, but at the level of transcription by the two-component system CseBC (M. S. 
Paget, Leibovitz, & Buttner, 1999).  This two-component system is transcribed in the same 
operon as σE, and serves to determine the stability of the cell wall in S. coelicolor (M. S. Paget et 
al., 1999).  
There is also evidence that suggest that ECF sigma factors are regulated by novel mechanisms, 
such as demonstrated with a subgroup of ECF sigma factors called ECF41.  ECF41 is a group of 
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ECF sigma factors that is uncharacterized, but widely distributed among prokaryotes.  Members 
of this group do not appear to be transcriptionally linked to anti-sigma factors, but are instead 
flanked by highly conserved genes that encode oxidoreductases, epimerases, or 
carboymuconolacetones, suggesting that these genes may play a role in regulating sigma factor 
activity (Wecke, Veith, Ehrenreich, & Mascher, 2006).  In addition, these ECF sigma factors are 
characterized as having an extended C-terminal domain that is thought to autoregulate their 
activity (Wecke et al., 2006).  Recent studies have explored these hypotheses and found that in B. 
licheniformis the flanking genes do not appear to play a role in the regulation of the ECF sigma 
factors.  However, Wecke et. al. present evidence that suggests the C-terminal domain is 
involved in controlling sigma factor activity through an unknown mechanism (Wecke et al., 
2006).  σJ of M. tuberculosis, another member of the ECF41 subgroup, is involved in the 
response to hydrogen peroxide, and is flanked by a conserved oxioreductase that is hypothesized 
to be involved in the regulation of this sigma factor by an unknown mechanism (Hu et al., 2004).  
Sigma Factors of S. aureus.  S. aureus is an extremely successful pathogen that regulates its 
gene expression through the use of two component regulators, DNA-binding proteins and sigma 
factors.  Curiously, for such a successful pathogen, S. aureus oversees its complex network of 
regulatory events with a limited number of sigma factors (Deora, Tseng, & Misra, 1997), , 
(Helmann, 2002), (Kill et al., 2005), (Kuroda et al., 2001), (Morikawa et al., 2003; Shaw et al., 
2008),.  The primary σ factor, σA, is the essential housekeeping σ factor and is responsible for 
transcription of genes for basic metabolic function (Deora & Misra, 1995, 1996).  The alternative 
sigma factor, σB, is closely related to σB of B. subtilis, and is the major stress response element in 
the cell (Deora et al., 1997).  σB has been shown to be involved in the virulence of S. aureus, 
likely by aiding in regulating virulence determinant expression, as a sigB mutant was found to be 
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attenuated in its ability to cause infection using a murine model of septic arthritis (Horsburgh et 
al., 2002).  sigB mutants have also been shown to have a decreased ability to form biofilms, 
likely due to the increase in production of extracellular proteases (Atwood et al., 2015).  σB of S. 
aureus has also been shown to be involved in the response to alkaline, oxidative, and heat shock 
(Deora et al., 1997), (Abdelnour, Arvidson, Bremell, Ryden, & Tarkowski, 1993), (Pane-Farre, 
Jonas, Forstner, Engelmann, & Hecker, 2006).  The activity of σB is regulated post 
translationally, similar to the σB homolog of B. subtilis, by a signal transduction mechanism 
involving its anti-sigma factor, RsbW, and an anti-anti-sigma factor, RsbU (Senn et al., 2005).  
The third σ factor of S. aureus, σH, shares homology to the Bacillus subtilis σH, and has a role in 
the regulation of competence genes, and in the integration and excision of prophages (Morikawa 
et al., 2003), (Tao, Wu, & Sun, 2010).  The σH gene is regulated by two unique mechanisms:  
The first is by a duplication rearrangement of the sigH gene with either nusG or rplK, two genes 
transcribed immediately downstream (Peschel et al., 2012).  This rearrangement results in a 
chimeric gene that allows for the translation of a chimeric functional σH (Peschel et al., 2012).  
The second mechanism is through post-transcriptional regulation via an upstream inverted repeat 
that prevents translation of the σH protein (Peschel et al., 2012).  These 13 base pair inverted 
repeats form a stable stem-and-loop structure that sequesters the ribosomal binding site of sigH 
transcript (Peschel et al., 2012).  The fourth, and final, σ factor, σS, was recently discovered in 
our laboratory and belongs to the ECF subfamily of σ factors (Shaw et al., 2008).   
The Lone ECF Sigma Factor of S. aureus, σS.  The sigS locus is conserved amongst the 
staphylococci and consists of σS and two downstream genes.  These genes are grouped together 
amongst all sequenced S. aureus genomes, perhaps suggesting that they serve a common 
function.  As previously stated, many ECF sigma factors are co-transcribed with a cognate anti-
! 29!
sigma factor, which is commonly a transmembrane protein (Helmann, 1999) (Hughes & Mathee, 
1998).  The downstream gene, SAOUHSC_01898 (ecfX) does appear to be transcriptionally 
linked to sigS; however, hydrophobicity plots indicate that there are no transmembrane regions 
within its encoded protein.  A second downstream gene, ecfY, which is divergent to sigS, is 
predicted to have 2 transmembrane domains.  Neither of these genes fit the classical anti-σ factor 
model, which could indicate that a novel mechanism of regulation for sigS is in place.  Previous 
work performed in our lab demonstrates that a sigS mutant is more sensitive to lysis by Triton X-
100 than the wild-type.  In addition, the sigS mutant is outcompeted by its parental strain in long-
term growth experiments under standard laboratory conditions, and in the presence of chemical 
stressors (hydrogen peroxide, diamide, hydrochloric acid, sodium hydroxide, EDTA, penicillin G 
and ethanol).  Using a murine model of septic arthritis, it was found that sigS is required for full 
virulence of S. aureus (Shaw et al., 2008).  Transcriptional studies of sigS using a lacZ fusion 
demonstrate no expression of this element in several strains of S. aureus under standard 
laboratory conditions, other than in the highly mutated strain RN4220 (Miller et al., 2012).  This 
differential expression of sigS is not attributed to single nucleotide polymorphisms (SNPs) in the 
promoter region of sigS, which is identical in all strains.  Our laboratory has previously 
demonstrated that sigS expression can be induced in the strain 8325-4 in response to a number of 
chemical stressors that include cell wall targeting antibiotics and DNA damaging agents.  In 
addition, our group also demonstrated that sigS expression is highly induced when S. aureus is 
challenged by components of the immune system, and upon phagocytosis by murine 
macrophage-like cells, RAW 264.7. 
Project Aim.  The regulation of gene expression is a fundamental property to all living systems 
that allows them to adapt and respond to different environmental conditions.  For pathogenic 
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bacteria, it is important to coordinate virulence gene expression, which is orchestrated by a 
variety of factors, including sigma factors.  Previous transcriptional studies by our group have 
demonstrated expression under standard conditions of sigS in the highly mutated strain RN4220, 
while expression is not detectable in 8325-4, SH1000, Newman and USA300.  The differential 
expression of sigS amongst the different S. aureus strains would suggest a tight level of 
regulation.  Therefore, the aim of this research is to elucidate mechanisms that are involved in 
the regulation of sigS.  The sigS locus is conserved amongst the sequenced staphylococci and this 
suggests that they serve a common function.  Preliminary work in our lab has indicated that EcfX 
may interact with σS, while ecfY may negative regulate this ECF sigma factor by a novel 
mechanism.  Therefore, we aim to investigate the contribution EcfX and EcfY make to 
expression of sigS. Finally, in a separate, unrelated line of investigation, we aim to tackle the 
problem of limited antibacterial therapeutics for S. aureus infections by testing the efficacy of a 
library of quinazoline derivatives.  It has previously been demonstrated that quinazoline based 
compounds are effective both in vivo and in vitro against a broad range of pathogens, including 
E. coli, P. aeruginosa, Plasmodium spp and Leishmania spp making them an ideal drug 
candidate.  Collectively, the results of this study will further our understanding of the complex 
regulatory network of S. aureus and elucidate novel mechanisms of ECF sigma factor regulation, 
in addition to developing novel antimicrobial agents that are effective against this organism. 
  
! 31!
 
 
CHAPTER TWO: 
INVESTIGATING THE GENETIC REGULATION OF THE ECF SIGMA FACTOR σS 
IN STAPHYLOCOCCUS AUREUS 
Note To Reader.   These results have been previously published (Burda et. al., 2014) with the 
permission of the publisher and the published manuscript can be found in Appendix 2. 
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CHAPTER THREE: 
A NOVEL ANTISENSE GOVERNED MECHANISM REGULATES σS PRODUCTION 
IN STAPHYLOCOCCUS AUREUS 
Abstract.  Our group has previously identified an ECF sigma factor, σS that is involved in the 
stress and virulence responses of S. aureus.  In this study we explore the sigS locus, and find that 
a downstream protein, EcfX, not only binds to σS, but is seemingly a positive activator of its 
ECF-sigma factor activity. In addition, we observed through RNAseq analysis that the majority 
of transcription in this region actually originates from a gene (ecfY) that is downstream and 
divergent to sigS. We demonstrate that inactivation of ecfY, leads to a significant increase in sigS 
and ecfX expression; alongside increased resistant to UV, H2O2, MMS, and ethidium bromide, 
conditions which a sigS mutant is highly sensitive to.  Our studies also revealed that an ecfY null 
strain is better able to survive intracellularly following phagocytosis and demonstrates increased 
survival in whole-human blood, while a sigS mutant is more sensitive when challenged with 
components of the immune system.  Because the ecfY null strain is a sigS overexpressing strain, 
we investigated the σS regulon using RNAseq analysis and identified genes under its control that 
are involved in virulence, DNA damage and repair, amino acid starvation and nucleotide 
biosynthesis.  Collectively, we demonstrate that the ECF-sigma factor in S. aureus, σS, is 
regulated via unique methods: positively thought the apparent need for an activator protein, and 
negatively via RNA-RNA interaction. We contend that this adds unique knowledge, not only to 
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our understanding of S. aureus regulatory circuits, but also to alternative sigma factor biology in 
general. 
Introduction.  The regulation of gene expression is a fundamental property of all living systems 
that allows them to adapt and respond to different environmental conditions.  Bacteria are 
constantly faced with ever-changing environments, and their ability to respond quickly to these is 
vital for survival.  In the context of pathogenic bacteria, it is important to coordinate virulence 
factor expression, so as not to waste resources and energy transcribing genes involved in 
pathogenesis when not inside the host. Such control is orchestrated by a variety of systems, 
including two-component systems, quorum sensing systems and DNA binding proteins.  
Regulation can occur at the level of transcription, translation and post-translation, with the 
primary point being at the level of transcription.  In bacteria, transcription is mediated by the 
multi-subunit enzyme RNA polymerase (RNAP), which consists of two functional forms: core-
RNAP and the holoenzyme.  Core-RNAP is responsible for transcription elongation and consists 
of two α subunits, and one each of ω, β, and β’ subunits (Gruber & Gross, 2003), (Ishihama, 
2000).  In order for the holoenzyme to initiation transcription, it must first associate with a sigma 
factor (Burgess, 1969).  Sigma factors are essential in promoter recognition and promoter 
melting; without them there would be no transcription.  All bacteria have a primary sigma factor 
usually designated σA that is responsible for the transcription of most genes, including those with 
housekeeping functions (e.g. cell wall synthesis, central metabolism, the replication machinery 
etc.).   
In addition to the primary sigma factor, there also exist alternative sigma factors, which control 
subsets of genes that are involved in specialized cellular functions and/or stress response (e.g. 
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oxidative stress, heat shock, etc.) (Kazmierczak, Wiedmann, & Boor, 2005).  Bacteria employ 
multiple sigma factors to allow the cell opportunities to change gene expression based on 
differences in promoter selectivity exerted by each sigma factor in response to specific 
environmental stimuli.  The largest and most diverse class of alternative sigma factors is the 
extracytoplasmic function sigma factors (ECF), of which there are predicted to be an average of 
six encoded per bacterial genome (Staron et al., 2009).  ECF sigma factors are a subfamily of the 
σ70 family of sigma factors, and typically respond to environmental stress, such as alkaline and 
heat shock (Cao et al., 2002), (Hahne et al., 2010), (Jervis, Thackray, Houston, Horsburgh, & 
Moir, 2007), (Potvin et al., 2008), (R. Manganelli et al., 2001), (Thackray & Moir, 2003); 
however, recent evidence suggests that these sigma factors also respond to cytoplasmic stimuli 
(Campbell et al., 2007), (Dufour et al., 2008), (Francez-Charlot et al., 2009), (Newton & Fahey, 
2008), (M. S. B. Paget et al., 2001), (S. T. Park, Kang, & Husson, 2008). 
A hallmark of ECF sigma factors is that they are typically regulated in a post-translational 
manner, in which they are co-transcribed with a cognate anti-sigma factor that binds to, and 
inhibits, the ability of the ECF sigma factor to associate with RNAP and initiate transcription 
(Helmann, 1999), (Hughes & Mathee, 1998).  Prototypically, anti-sigma factors contain at least 
one transmembrane domain and interact with their cognate ECF sigma factor through a 
conserved N-terminal region, while the C-terminal domain is located in the extracellular space, 
sensing environmental surroundings (Helmann, 1999), (Hughes & Mathee, 1998), (Staron et al., 
2009).  As the number of ECF sigma factors identified increases, however, it becomes apparent 
that not all of them are regulated in this way.  In recent years, a number of novel mechanisms for 
controlling ECF sigma factor activity have been identified (Jordan, Junker, Helmann, & 
Mascher, 2006), (Kang et al., 1999), (M. S. B. Paget et al., 2001), (W. Li et al., 2002), (Hong, 
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Paget, & Buttner, 2002), (Staron et al., 2009).  Contrary to the classical transmembrane bound 
anti-sigma factor, recent studies reveal that soluble anti-sigma factors exist that are responsible 
for sensing cytoplasmic stress (Campbell et al., 2007), (Dufour et al., 2008), (M. S. B. Paget et 
al., 2001), (S. T. Park et al., 2008). For example, in Streptomyces coelicolor, the ECF sigma 
factor σR is regulated by its cognate anti-sigma factor, RsrA (Kang et al., 1999), (M. S. B. Paget 
et al., 2001),, which has no transmembrane domains. Instead, it resides in the cytoplasm where it 
binds to σR and prevents it from initiating transcription (Kang et al., 1999), (W. Li et al., 2002), 
(M. S. B. Paget et al., 2001),.  When S. coelicolor experiences disulfide stress, RsrA forms an 
intramolecular disulfide bond that leads to a conformational change, and the release of σR (Bae et 
al., 2004), (W. Li et al., 2002), (M. S. B. Paget et al., 2001), (Zdanowski et al., 2006).  In 
addition, σE of S. coelicolor has no cognate anti-sigma factor, but is instead regulated at the level 
of transcription by the two-component system CseBC in response to cell wall perturbation (Hong 
et al., 2002).  Other studies have suggested that some ECF sigma factors, including σJ of 
Mycobacterium tuberculosis, are flanked by conserved, uncharacterized genes that may act to 
regulate sigma factor activity by as yet unidentified mechanisms (Staron et al., 2009), (Wecke et 
al., 2006).  Furthermore, there have been ECF sigma factors described that are not associated 
with an anti-sigma factor at all, but rather encode an extended C-terminal tail that acts to regulate 
sigma factor activity (Hu et al., 2004), (Staron et al., 2009).   
With its complex pathogenic lifestyle, it would be unsurprising if the Staphylococcus aureus 
genome encoded several ECF sigma factors, especially with the prominent role these 
transcriptional regulators play in virulence; however, to date only one (σS) has been identified 
(Shaw et al., 2008).  Previous work by our group has demonstrated that purified σS is able to bind 
to and direct transcription from its own promoter (Shaw et al., 2008).  In addition, we have 
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shown that a sigS mutant is more sensitive to lysis by Triton X-100, and is outcompeted in long-
term growth experiments by the parent strain under both standard growth conditions and in the 
presence of chemical stressors.  Most importantly, perhaps, we have demonstrated that sigS is 
required for full virulence in S. aureus using a murine model of septic arthritis (Shaw et al., 
2008).  At the level of transcription, it appears that sigS is not expressed under standard 
conditions, except in the highly mutated strain, RN4220. We have shown sigS upregulation in 
other strains using a number of chemical stressors, including those that elicit damage to DNA 
and the cell wall (Miller et al., 2012).  Further to this, expression of sigS is seemingly 
upregulated when challenged by components of the immune system, and during phagocytosis by 
murine macrophage-like cells (Miller et al., 2012).  From a genetic perspective, sigS is directly 
regulated by CymR, the master regulator of cysteine biosynthesis in S. aureus, and KdpE, the 
response regulator of the two-component system KdpDE, which mediates potassium uptake and 
sensing cyclic-diAMP (Burda et al., 2014), (Corrigan & Gründling, 2013), (Soutourina, Dubrac, 
Poupel, Msadek, & Martin-Verstraete, 2010; Soutourina et al., 2009), (Xue, You, Hong, Sun, & 
Sun, 2011). However, to date, no anti-sigma factor for σS has been identified. 
While exploring the operon architecture of the sigs locus by RNAseq analysis, we observed an 
interesting phenomenon in which there is extended read through from the gene ecfY, which is 
downstream and divergently transcribed. In this study we described the inactivation of ecfY, and 
demonstrate that its long 3’ UTR has a strongly inhibitory effect on sigS expression. 
Furthermore, the ecfY mutant has opposing phenotypes to a sigS mutant; in that it is more 
resistant to DNA damaging agents and components of the innate system, which we hypothesize 
is due to overexpression of sigS.  Finally, we perform RNAseq analysis with the ecfY to gain 
insight into the σS regulon. Collectively, we present evidence that the ECF sigma factor, σS, is 
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regulated in a unique manner, whereby it is influenced at the post-transcriptional level by the 
downstream gene ecfY. 
Bacterial strains and growth conditions. S. aureus and E. coli strains, along with plasmids and 
primers, are listed in Table 2.  E. coli was grown in Lysogeny Broth (LB) at 37ºC with shaking 
at 250 rpm.  S. aureus was grown in Tryptic Soy Broth (TSB) at 37ºC with shaking at 250 rpm, 
unless indicated otherwise.  Synchronized cultures were obtained as previously described (Shaw 
et al., 2008).  When required, antibiotics were added at the following concentrations:  ampicillin 
100 µg ml-1, tetracycline 5 µg ml-1, erythromycin 5 µg ml-1, lincomycin 25 µg ml-1, rifampicin 
1.5 µg ml-1, 0.6 µg ml-1 ciprofloxacin and chloramphenicol 10 µg ml-1.   
Northern blot analysis.  Synchronized cultures of relevant bacterial strains were grown in TSB 
for 3 h.   Cell pellets were resuspended in 100 µl TE buffer, added to lysing matrix D (MP 
Biomedical) and cells lysed using a Minibeadbeater (Biospec Products).  RNA was extracted 
using an RNeasy Plus Mini Kit according to the manufacturer’s protocol (Qiagen).  RNA 
samples were then mixed at a 1:2 ratio with Gel Loading Buffer II (Life Technologies) and 
incubated at 95°C for 5 minutes before being loaded on a 1.5% agarose gel containing 2.2 M 
formaldehyde; which was subsequently run at 65 V for 180 minutes.  The fractionated RNA 
samples were then transferred to an uncharged nylon membrane by upward capillary transfer..  
Following this, the RNA was covalently linked to the membrane by UV irradiation.  The 
resulting membrane was then pre-hybridized in 10 ml ULTRAhyb Ultrasensitive Hybridization 
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Table 2. Strains, plasmids and primers used in this study. 
Strain, 
primer, or 
plasmid 
Genotype or description Reference 
   
E. coli   
DH5α φ80 Δ(lacZ)M15 Δ(argF-lac)U169 endA1 recA1 hsdR17 (rK-mK+) deoR thi-1 supE44 gyrA96 
relA1 
 
Sambrook 
BL21 (DE3)pLysS Promega 
   
S. aureus   
RN4220 Restriction deficient transformation recipient Lab 
stocks 
USA300 
Hou 
Sequenced USA300 HOU-MRSA isolate cured of pUSA300-HOU-MRSA Kolar et 
al  
   
Plasmid   
   
pMK4 Shuttle vector Sullivan 
pMAL-
C2a 
  
N-terminal Maltose Binding Protein tag expression vector New 
England 
Biolabs 
pET24d+ C-terminal 6XHis tag expression vector Novagen 
   
Primers1   
   
OL1115 ATGACCATGGTGCAAGACAATTCTACTAAATATC  
OL1116 ATGACTCGAGCTTCATTGAAAATACTATTTCGAAT  
OL1184  AGCCGACCTGAGAGGGTGA  
OL1185  TCTGGACCGTGTCTCAGTTCC  
OL1366  ACGTGCACCGATACAA  
OL1367  GGCTCATCAACTTCTAGC  
OL1471  TTTATGGTACCATTTCATTTTCCTGCTTTTTC  
OL1550  ATGGGATCCGGGATGATGGTAACAGTG  
OL1551  ATGGTCGACTTATTTATCATCATCATCTTTATAATCTTTCGAATTAAATTTAATTTC  
OL1568 CGATTACGCAAATGAATG  
OL1569 CAAGTAGTCATTCTCCAAG  
OL1903  ATGGAATTCTTGAAATTTAATGACGTATACAAC  
OL1904 TGCTCTAGACTAATTAAAATTATGTTGGCATTTACGC  
OL2393 TCGTATGTTGTGTGGAATTG  
OL2394  GTGCTGCAAGGCGATTAAG  
OL2952 GATGTCCGTTAAGCGTAAATGCCAAC  
OL3362  ATGATGGGATCCGTACTTCACTGACAACTATGCCG  
OL3363  ATGGTCGACGTGGTGGTGGTGGTGGTGTTTCGAATTAAATTTAATTTCTAAAAG  
OL3366  GGTAACAGGCTTATTTAAGTTAACGCTG  
OL3446 CGTTAAACTTAATAAGCCTGTTACC  
OL3447 GGGCTAATTACAAGTCTATCTG  
  
1Restriction Enzyme sites are underlined  
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 Buffer (Ambion) at 42°C in a hybridization oven (UVP HB-1000) for 1 h.  During this time, 
probes specific for ecfY (OL3366) were end labeled with P32 using T4 polynucleotide kinase 
(NEB), and any un-incorporated P32 removed using a nucleotide cleanup kit according to the 
manufacturer’s protocol (Qiagen).  The labeled probe was then denatured by heating to 95°C for 
5 minutes, before being added directly to the pre-hybridization solution and incubated overnight 
at 42°C.  Membranes were washed three times in 10 ml of: 2X saline-sodium citrate (SSC) 
buffer, 1X SSC and 0.5X SSC.  The resulting membrane was then exposed to X-ray film for 7 
days. 
Introduction of ecfY transposon mutant into S. aureus USA300.  An ecfY::bursa aurealis 
insertion in S. aureus USA300 strain JE2 was acquired from the Nebraska Transposon Mutant 
Library.  This transposon insertion is 40 nucleotides from the end of the gene and oriented 
antisense to the coding region of ecfY.  The ecfY::bursa aurealis construction was introduced 
into the USA300 Houston (Hou) wild-type strain via φ11 mediated transduction, as described by 
us previously (C. N. Krute et al., 2015).  Successful transduction was confirmed by PCR analysis 
using primers OL1471, which is specific to the transposon, and OL1550, which is specific to 
ecfY.   
Construction of ecfY complement strains.  Two ecfY complementation constructs were 
generated: one that contains the promoter and coding region of ecfY (using primers OL3362 and 
OL3363) and one that contains the promoter, the coding region and a 1kb fragment that extend 
3’ of ecfY and includes sigS and ecfX (using primers OL1550 and OL1551). These fragments 
were then cloned into the Gram-positive shuttle vector, pMK4, (Sullivan, Yasbin, & Young, 
1984), with the resulting plasmids transformed into chemically competent E. coli DH5α.  
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Successful transformation was determined by PCR analysis using a combination of gene specific 
primers (OL3362/OL3363 for ecfY alone or OL1550/OL1551 for ecfY and the extended 3’ UTR) 
and primers specific to pMK4 (OL2393/OL2394).  Additionally, Sanger sequencing using 
plasmid specific primers was performed to confirm fidelity of the construct.  These plasmids 
were then transformed into S. aureus RN4220 by electroporation and confirmed by PCR, again 
using a combination of gene specific and plasmid specific primers.  Correct clones were 
introduced into the USA300 Hou ecfY::bursa aurealis strain by φ11 mediated transduction and 
confirmed by PCR. 
Quantitative Real-Time PCR.  Quantitative real-time PCR was performed as previously 
described using primers specific to sigS, ecfX, and ecfY (Burda et al., 2014), (Miller et al., 2012).  
Expression of ecfX and ecfY was determined using primer pairs OL1366/OL1367 and 
OL3446/OL3447, respectively.  The 16S rRNA gene was used as a control, as previously 
described (Koprivnjak et al., 2006).   
DNA damage sensitivity assays.  Sensitivity to DNA damaging agents were determined as 
previously described (Miller et al., 2012).  Briefly, exponentially growing cultures were washed 
and resuspended in phosphate buffered saline (PBS) before the addition of DNA damaging 
agents: 1.1 M H2O2, 25 mM MMS and 2 mg ml-1 ethidium bromide.  Cultures were placed at 
37°C with shaking and aliquots were removed at the time intervals specified.  Samples were then 
serial diluted and CFU ml-1 were determined alongside control samples that were removed prior 
to exposure.  Percent survival was determined by comparing the initial CFU ml-1 to final CFU 
ml-1 from three independent experiments.  Statistical significance was determined using a 
Student t test with a 5% confidence interval. 
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UV radiation survival assay. UV radiation survival assays were performed as previously 
described (Miller et al., 2012). 
Purification of recombinant σS, EcfX and LAP.  The coding region of ecfX was amplified by 
PCR using primers OL1115 and OL1116.  This fragment was then subjected to restriction 
enzyme digest using NcoI and XhoI and cloned into a similarly digested pET24d+.  The resulting 
construct was then transformed into DH5α and confirmed by restriction enzyme digest.  Any 
clones that were correct were then verified by Sanger sequencing using a T7 promoter primer 
and a T7 terminator primer that flanks the multiple cloning site of pET24d+.  The resulting 
plasmid was then transformed into E. coli BL21(DE3)pLysS.  Recombinant LAP was generated 
as previously described (Carroll et al., 2013).  Expression of ecfX and pepZ (the gene encoding 
LAP) was induced with the addition of 1 mM isopropyl-1-thio-β-Dgalactopyranoside (IPTG) to 
exponentially growing 1 liter cultures (OD600 = 0.6), and allowed to incubate for 5 h at 37°C.  
EcfX and LAP were then purified as previously described (Burda et al., 2014), (Carroll et al., 
2013).  Following elution, purified proteins were dialyzed for 48 hours against dialysis buffer (50 
mM NaH2PO4, 300 mM NaCl, pH 8.0), with purified proteins stored in dialysis buffer 
supplemented with 10% glycerol at -20°C.   
For σS, its coding region was amplified by PCR using primers OL1903 and OL1904, and ligated 
into pMAL-C2a. This generates a hybrid of the malE gene of E. coli followed by the sigS coding 
region, which, upon induction, generates a σS protein fused to the maltose binding protein 
(MBP). The resulting construct was then transformed into DH5α and confirmed by restriction 
enzyme digest.  Any clones that were correct were then verified by Sanger sequencing using an 
M13 forward and an M13 reverse primer that flanks the multiple cloning site of pMAL-C2a.  
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The resulting plasmid was then transformed into competent BL21(DE3)pLysS, and the 
expression of sigS was induced with 1 mM IPTG to exponentially growing 1 liter cultures 
(OD600 = 0.6), and allowed to incubate for 5 h at 37°C.  Cells were then harvested by 
centrifugation and resuspended in 25 ml of column buffer (20 mM Tris-HCl, 200 mM NaCl and 
1 mM EDTA).  Lysozyme was added at a concentration of 1 mg ml-1 and then incubated at 37°C 
for 1 h, in order to lyse the cells.  Following this, the sample was sonicated on ice for a total of 3 
minutes and clarified by centrifugation at 9,000g for 15 minutes.  The supernatant was diluted in 
125 ml of column buffer, added to an amylose column and then washed with 12 column volumes 
of column buffer.  MBP-σS was eluted from the column in column buffer containing 10 mM 
maltose.  Following elution, the purified protein was dialyzed for 48 hours against a dialysis 
buffer, with purified proteins stored in dialysis buffer supplemented with 10% glycerol at -20°C. 
Protein pull down assay.  In an effort determine if σS and EcfX interact we performed a pull 
down assay using recombinant versions of each protein.  Purified MBP-σS was applied to an 
amylose column and incubated at room temperature for 20 minutes before being washed with 25 
ml of column buffer.  Following this, purified EcfX was added and allowed to incubate for 1 h at 
room temperature.  To reduce non-specific protein interaction, the column was then washed with 
25 ml of wash buffer (50 mM NaH2PO4, 300 mM NaCl and 20 mM imidazole, pH 8.0) before 
any remaining proteins were eluted with column buffer containing 10 mM maltose.  Samples 
were then run on an SDS-PAGE gel followed by western blot analysis using an anti-6X His 
antibody (specific for the recombinant EcfX protein).  In order to determine if the interaction of 
σS and EcfX was specific, the pull down assay was repeated in an identical fashion, however 
purified LAP (a leucine aminopeptidase unrelated to the σS system (Carroll et al., 2013)) was 
used in place of EcfX, as a negative control.  
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Macrophage survival assay.  A macrophage survival assay was performed using RAW 264.7 
cells as described by us previously (Miller et al., 2012).   
RNAseq analysis.  RNAseq analysis of the USA300 wild-type and the ecfY::bursa aurealis 
strain, both grown in TSB for 3h, was performed as described by us previously (Christina N. 
Krute et al., 2015; Weiss, Ibarra, Paoletti, Carroll, & Shaw, 2014). 
Bioinformatic analysis to determine the conserved sigS gene cluster in the staphylococci. In 
an attempt to provide insight into potential anti-sigma factors of σS, we first performed a 
bioinformatics analysis to identify genes that cluster with its coding region in the staphylococci. 
When one looks at the sigS locus in S. aureus and other staphylococcal species one notes that it 
is always clustered together with the same gene upstream, and the same 2 genes downstream 
(Figure 2). When one performs bioinformatic analyses on the proteins produced by these 4 
genes (SAUSA300_1721, sigS, ecfX and ecfY), EcfX is the only protein to have detectable 
homology other than σS. In the context of EcfX, it seemingly possesses sequence homology to 
the master regulator of competence in B. subtilis, ComK (Table 3). Interestingly, these same 
genes also clustered together in the closely related bacterium Macrococcus caseolyticus (Figure 
2), although this is perhaps unsurprising as the former name of this organism was 
Staphylococcus caseolyticus until 17 years ago (Kloos et al., 1998). Other than these organisms, 
as suggested by us previously (Shaw et al., 2008), we were unable to find this collection of genes 
clustered together in the genome of any other bacterial organism outside of the staphylococci. 
!  
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Figure 2.  Genomic analysis of the sigS locus in the staphylococci and the closely related 
organisms.  A schematic representation of the genomic context of the sigS locus in selected 
staphylococci species and M. caseolyticus. The genomic alignment was made using the 
Integrated Microbial Genomes (IMG) website (http://img.jgi.doe.gov).  The alignment was 
generated using all of the available staphylococcal genomes in the IMG database(20 organisms).  
The sigS locus consists of SAUSA300_1721, sigS, ecfX and ecfY, which are always clustered 
together (denoted by black box). The sigS gene is indicated by the arrow and is highlighted red.!  
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Table 3.   Genes found within the conserved sigS cluster in the staphylococci. 
Annotation Gene Function 
SAUSA300_1721  Conserved hypothetical protein 
SAUSA300_1722 sigS ECF sigma factor 
SAUSA300_1722.1* ecfX Conserved hypothetical protein 
SAUSA300_1723 ecfY Conserved hypothetical protein 
 
*ecfX is annotated herein as SAUSA300_1722.1 because it is not contained within the original genome annotation 
file for the USA300 strain. 
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The cognate gene to sigS, ecfX, encodes a protein that enhances, rather than represses, σS 
activity. It is not uncommon for ECF sigma factors to be co-transcribed with one or more 
negative regulators (Helmann, 2002), (Missiakas & Raina, 1998). Given the 112bp spacing 
between sigS and ecfX, and the lack of an obvious transcriptional terminator, it appears likely 
that these two elements are transcriptionally linked to each other.  Previous studies in our lab 
using a sigS-lacZ fusion, have indicated that in the absence of ecfX there is none of the enhanced 
sigS expression that would be expected if this gene encodes an anti-sigma factor, at least in strain 
SH1000 (Shaw et al., 2008).  Indeed, we observed no detectable expression of sigS in the ecfX 
mutant after 1 week of incubation of plates containing X-Gal (Shaw et al., 2008).  Therefore, we 
decided to evaluate the expression of sigS in an ecfX mutant via qPCR in strain RN4220, as we 
have previously demonstrated expression of sigS in this strain under standard conditions (Figure 
3.A).  Surprisingly, we observed a significant decrease (59.6 fold) in sigS expression in the ecfX 
mutant. To corroborate these findings in other strains, we also evaluated the expression of sigS in 
an ecfX mutant in the USA300 background. Upon analysis we also observed decreased 
expression of sigS (Figure 3.A), collectively suggesting that EcfX is a positive regulator of sigS 
expression.   
Interestingly, during our analysis of the sigS loci we discovered that in the ancient 
staphylococcal species S. carnosus, sigS and ecfX are actually annotated as a single gene, 
encoding a single protein.  This lead us to hypothesize that sigS and ecfX genes arose as a single 
unit that has since diverged into two separate genes/proteins in other staphylococcal species, but 
that may still function together. In order to determine if σS and EcfX in S. aureus interact we 
performed a pull down assay using purified recombinant proteins.  To do this, a recombinant σS 
that is fused to the maltose binding protein (MBP) of E. coli was generated and applied to an  
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Figure 3. EcfX is a positive activator of σS. (A) qPCR analysis of sigS expression in an ecfX 
mutant compared to RN4220 and USA300 parental strains.  RNA was extracted from cultures 
grown in TSB for 3 h.  Error bars are shown as ± SEM, *** = p < 0.001 and **** = p < 0.0001 
using a Student’s t-test. (B) A protein pull down was performed using purified recombinant σS, 
EcfX and LAP.  In the + columns EcfX or LAP was incubated with σS, while in the – column 
EcfX or LAP was incubated in the presence of amylose resin alone.  These samples were then 
run on an SDS PAGE gel and subjected to western blot analysis using an anti-6X His antibody, 
which is specific for EcfX and LAP.  The first lane contains purified MBP-σS, whilst the last two 
columns contain purified EcfX and LAP. 
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amylose column. This approach allowed us to anchor σS to the column as a result of the N-
terminal MBP tag. The column was then washed, before the addition of recombinant EcfX-His6. 
The protein complex was then washed, eluted and run on an SDS-PAGE gel; followed by 
subsequent Western blot analysis using an antibody specific to the hexahistidine tag (Figure 
3.B).  In so doing we observed that when σS was incubated with EcfX a band was visualized at 
approximately 15 kDa (the EcfX + column in Figure 3.B), which is the molecular weight of 
EcfX.  This interaction is specific to the σS protein because we did not observe a band when 
EcfX was incubated with the amylose resin alone (e.g. in the absence of σS, denoted as the – 
column in Figure 3.B).  In order to determine if the σS-EcfX interaction was specific, and not the 
result of promiscuous binding, we repeated these analyses using purified LAP (also bearing a C-
terminal hexahistidine tag) in place of EcfX. Importantly, when this pairing was tested we 
observed no band in either lane with or without σS, indicating that the interaction of this ECF-
sigma factor is specific to EcfX. 
Exploring the architecture of the sigS operon using RNAseq. When analyzing RNAseq data 
previously generated in our laboratory for wild-type S. aureus (Weiss, Ibarra, Paoletti, Carroll, & 
Shaw, 2014), we noted something unusual about the sigS locus. Specifically, we found that 
almost all transcripts in this sigS-ecfX region appears to originate from extended read through of 
ecfY, which is encoded in the opposite orientation to sigS and ecfX (Figure 4.A).  This would 
suggest that the low expression of sigS and ecfX observed under standard laboratory conditions 
might be explained by read through from the ecfY transcript.  In order to explore this further, we 
first set out to confirm the overly large ecfY transcript size predicted by RNAseq, using northern 
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blot analysis. This was performed on RNA extracted from the USA300 wild-type and a probe 
that is specific to ecfY (Figure 4.B).  If the ecfY transcript does indeed have the RNAseq  
predicted large 3’ UTR, then the size of the band would be approximately 1.5 kilobases (kb); 
however, if the transcript only contains the ecfY gene without a 3’ UTR, then there would be a 
band visible at 450 bp.  Upon analysis, we observed a band of 1.5 kb, which would indicate that 
the ecfY transcript continues beyond its transcriptional stop codon, and reads in to ecfX and sigS 
(in an antisense fashion). This raises the possibility that the sigS-ecfX locus is subject to post-
transcriptional regulation resulting from the divergent partner gene, ecfY. Such an observation 
represents a novel form of ECF-sigma factor based regulation, and begins to explain the very low 
levels of sigS expression/synthesis in S. aureus cells. 
A mutation in ecfY leads to increased expression of sigS and ecfX.  Based on the RNAseq and 
northern blot data presented above, we hypothesized that in the absence of ecfY, we should 
observe an increase in sigS and ecfX expression under standard conditions. Whilst exploring the 
NTML web viewer, we noted a mutant was present in this collection where a transposon has 
inserted 40 bp from the stop codon of ecfY (and thus 400 bp from the start codon). Because of the 
close proximity of the bursa aurealis transposon insertion to the end of the gene, we 
hypothesized that this insertion would perhaps truncate the EcfY protein, and/or eliminate the 
long 3’ UTR. To explore these contentions, we first determined the orientation of the transposon 
relative to ecfY using a combination of gene and transposon specific primers (OL1471/1550 and 
OL1471/1551, Table 2). We found that the transposon had inserted into ecfY on the forward 
strand, while ecfY is encoded on the reverse strand, thus indicating that transcription from the 
transposon would run antisense to the ecfY transcript.  In order to determine if the ecfY transcript 
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Figure 4. Analysis of the sigS operon using RNAseq.  (A)  The architecture of the sigS operon 
as studied by RNAseq analysis in the USA300 wild-type strain. The red reads indicate 
transcription from the negative strand, while green reads indicate transcription from the positive 
strand.  (B) Northern blot analysis of the ecfY transcript in the USA300 wild-type (WT) and the 
ecfY transposon mutant strain. (C)  Schematic representation of complementation constructs used 
in this study, relative to panel A.  The ecfY-S construct includes only the coding region for ecfY, 
while the ecfY-L complement includes the coding region and the extended 3’ UTR. 
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 was affected by this insertion, we next repeated our northern blot analysis using the transposon 
mutant (Figure 4.B). Importantly, using our ecfY specific probe, we did not observe any 
transcript in the transposon mutant strain relative to the wild-type. As such, this would suggest 
that insertion of the transposon in an anti-sense orientation at the 3’ end of the ecfY gene 
effectively generates an ecfY knock-down strain. 
Given that the long ecfY 3’ UTR is absent (along with the rest of the ecfY transcript) in the 
transposon mutant, we next analyzed transcription of sigS and ecfX in the wild-type and mutant 
strain. In so doing we observed a remarkable 13.4 –fold increase in sigS expression, and a 6.4 –
fold increase in ecfX expression, in the ecfY knock-down strain, relative to the parent (Figure 5). 
This suggests that our hypothesis regarding the long 3’ ecfY UTR negatively impacting the 
expression of sigS and ecfX is indeed true. However, as the ecfY coding region is also absent in 
the transposon mutant, it is equally possible that a loss of EcfY protein results in this outcome. 
Indeed, EcfY is predicted to be a membrane protein (Figure 6), and would therefore be an 
obvious candidate to serve as a σS anti-sigma factor, apart from the fact it is not transcriptionally 
linked to sigS, as is traditional for such regulators (Helmann, 1999), (Hughes & Mathee, 1998). 
Nevertheless, this possibility could not thus far be excluded, and therefore our next approach was 
to complement the transposon mutant with two different fragments of the ecfY coding region: the 
first contained only the coding region of ecfY alone (ecfY-S), whilst the second contained the ecfY 
coding region along with the 3’ UTR extension (ecfY-L). The rationale for this approach was that 
if the ecfY-S complement successfully eliminated overexpression of sigS and ecfX in the ecfY 
transposon mutant, then this would suggest the effect is mediated by the EcfY protein; putatively 
as a classical anti-sigma factor. If, however, only the ecfY-L complement was able to abrogate 
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Figure 5. Transcriptional profiling of sigS and ecfX in an ecfY null strain. qPCR analysis of 
sigS (A) and ecfX (B) expression in the USA300 wild-type, ecfY null mutant strain, or the ecfY 
null strain complemented with either the ecfY-S or ecfY-L (see text for explanation).  RNA was 
extracted from cultures grown in TSB for 3h.  Error bars are shown as ± SEM, * = p < 0.05 **, = 
p < 0.01 and *** = p < 0.001  using a Student’s t-test. !  
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Figure 6.  Hydrophobicity plot of the EcfY protein in S. aureus.  A SOSUI topology map of 
the EcfY amino acid sequence indicates that this protein seemingly has two transmembrane 
domains.  
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 the enhanced expression of sigS and ecfX in the transposon mutant strain, then this would 
suggest the affect is mediated by a post-transcriptional, antisense RNA based mechanism. 
Accordingly, we next repeated the qPCR analysis of sigS and ecfX expression using these two 
complementing constructs, alongside the wild-type and transposon mutant strain. In so doing, we 
found that the  
ecfY-S complement alone did not reduce sigS and ecfX expression back to that of the wild-type, 
but instead mirrored the ecfY transposon mutant (Figure 5).  Indeed, only when we 
complemented with the ecfY-L construct did we successfully reduce sigS and ecfX expression 
back down to wild-type levels.  These results indicate that it is the ecfY transcript (and not the 
resulting EcfY protein) that negatively affects sigS and ecfX expression, seemingly through 
RNA-RNA based interaction, mediated by the long 3’ UTR of ecfY. 
ecfY and sigS mutants have opposing phenotypes in their resistance to DNA damage.  Given 
that we have demonstrated sigS overexpression in a strain lacking ecfY, we hypothesized that 
sigS and ecfY mutants may have opposing phenotypes when exposed to DNA damaging agents. 
The reason for this is that, in previous studies by our group, we have demonstrated that sigS 
expression is induced in the presence of DNA damaging agents (Miller et al., 2012), and that 
sigS mutants are highly sensitive to the DNA damaging agents MMS, ethidium bromide, H2O2 
and UV irradiation (Miller et al., 2012).  To test this notion, we exposed the wild-type and ecfY 
knock-down strain to 25 mM MMS for 30 minutes, and found that 24.1% of the transposon 
mutant cells survived relative to the initial inoculum, yet only 6.3% of wild-type cells were 
recovered (Figure 7.A).  Conversely, we recovered 2.7% of the sigS mutant, validating our 
hypothesis regarding the protective effects of sigS overexpression in the ecfY mutant.   
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Figure 7. ecfY and sigS mutants have opposing phenotypes in their resistance to DNA 
damage.  The USA300 wild-type, ecfY null strain, the sigS mutant, and the ecfY null strain 
complemented with either ecfY-S or ecfY-L (see text for explanation) were analyzed for viability 
in the presence of various DNA damaging-inducing stressors. Shown are data from exposures to 
25 mM MMS for 30 mins (A), 2 mg ml-1 Ethidium Bromide for 30 mins (B), 1.1 M H2O2 for 5 
mins (C), and 4000 µJ per cm2 of UV (D). CFU counts were determined both pre-and post-
exposure and the percent recovery was determined. Error bars are shown as ± SEM, * = p < 0.05, 
** = p < 0.01, and *** = p < 0.001 using a Student’s t-test.  Significance for all strains was 
determined relative to the wild-type strain (WT). !  
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Importantly, only the ecfY-L complementation construct restored the ecfY mutant to wild-type 
levels of survival, indicating the effect is mediated by sigS overexpression, rather than any loss 
of ecfY/EcfY. We next evaluated the ability of this same set of strains to survive exposure to 
ethidium bromide (Figure 7.B).  After 30 minutes incubation with 2 mg ml-1 ethidium bromide, 
we observed a 41.3% recovery of the wild-type when compared to the initial inoculum, while we 
recovered 99.5% of the ecfY null strain, which is a 2.4 fold increase in survival.  Again in 
contrast, we observed 14.4% survival of the sigS mutant relative to the initial inoculum, which 
was a 2.8 fold decrease when compared to the wild-type.  As we observed with our MMS 
survival assay, we were able to complement our results to wild-type levels with the ecfY-L 
complement strain but not ecfY-S.  Similar findings were also determined for the oxidizing agent 
H2O2 (Figure 7.C), as well as upon exposure to UV light (Figure 7.D), thus collectively 
confirming sigS overexpression in an ecfY mutant is protective to cells undergoing DNA damage 
stress. 
An ecfY null strain is better able to survive exposure to components of the innate immune 
response.  We have previously observed that sigS is required for survival when exposed to 
components of the innate immune response (Miller et al., 2012), (Shaw et al., 2008).  
Accordingly, we set out to determine the impact of ecfY knock-down on the infectious capacity 
of S. aureus.  This was first accomplished by the use of a macrophage survival assay to evaluate 
the ability of the wild-type and a ecfY null strain to survive following phagocytosis (Figure 8.A).  
We determined that at 24h post-infection, the ecfY null strain displayed a 2.2 fold increase in 
survival compared to the wild-type, whereas we observed a 2.7 fold decrease in viability of the 
sigS mutant in the same circumstances.  As with our previous complementation studies, the ecfY-
S construct was unable to reduce the ecfY mutant to wild-type survival levels, however the ecfY-L  
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Figure 8.   An ecfY mutant is better able to survive exposure to components of the innate 
immune response.  The USA300 wild-type (WT), ecfY knock-down strain, sigS mutant, and the 
ecfY knock down strain complemented with either ecfY-S or ecfY-L (see text for explanation) 
were assessed for viability 24h post phagocytosis by 264.7 RAW murine macrophage-like cells 
(A), or 2h post-inoculation in whole human blood (B). CFU counts were determined both pre-
and post-exposure and the percent recovery was determined. . Error bars are shown as ± SEM, * 
= p < 0.05, ** = p < 0.01, and **** = p < 0.0001 using a Student’s t-test.  Significance for all 
strains was determined relative to the wild-type strain (WT). 
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construct did. This again indicates that any survival advantage conferred on the ecfY mutant 
results from sigS overexpression, rather than any consequence of ecfY/EcfY ablation.  Further to 
this, we have also previously demonstrated that a sigS mutant is more sensitive when exposed to 
pooled whole human blood; therefore we also evaluated the ability of the ecfY transposon mutant 
strain to survive in these same conditions.  Exponentially growing cultures of the USA300 wild-
type, alongside its ecfY and sigS mutants were separately inoculated into whole human blood and 
incubated for 2h.  Upon analysis, we recovered 6.7% of the ecfY null strain compared to the 
initial inoculum, while we recovered only 1.4% of the wild-type, resulting in a 4.8 fold increase 
in the ability of the ecfY null strain to survive relative to the parent (Figure 8.B).  Conversely the 
sigS mutant had only a 0.3% survival rate compared to the initial inoculum, which is a 4.6 fold 
decrease compared to the parent. Our complementation studies again demonstrated that only the 
ecfY-L construct restored ecfY survival to that of the parental level. Collectively, these works 
again confirm the negative effects of the ecfY 3’ UTR on σS activity, and further support our 
previous findings regarding the importance of σS for S. aureus disease causation. 
Transcriptomic analysis of the ecfY knock-down strain.  Because sigS is not expressed under 
standard conditions, determining the regulon of this transcription factor using sigS-null strains 
has thus far proven uninformative (our unpublished data). Additionally, our efforts to assess the 
σS regulon using a sigS over-expressing strain have been thwarted because, despite correct 
construction, no strain ever yielded sigS overexpression (as assessed by qPCR, data not shown). 
Based on data presented herein, this latter finding is likely the result of the previously unknown 
inhibitory effects of the ecfY 3’ UTR on sigS-ecfX expression.  However, we show in the present 
study that in the absence of ecfY, true sigS overexpression is possible.  As such, we set out to 
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exploit this effect, and assess the influence of a mutation in ecfY (and thus sigS overexpression) 
on the transcriptome of S. aureus using RNAseq analysis (Figure 9).   
In so doing, we found that the expression of 179 genes was up regulated and 308 genes were 
down regulated by 2-fold or greater in the ecfY null strain compared to the parent. Ontologically, 
these changes grouped into 21 different categories (Figure 10, Table 4, Table 5 and Table 6), 
with the largest being those involved in amino acid biosynthesis. This is perhaps not unexpected, 
as we have previously demonstrated that the expression of sigS is upregulated in amino acid 
limiting media, and that expression of sigS is also influenced by the disruption of genes involved 
in amino acid biosynthesis (Burda et al., 2014), (Miller et al., 2012).  Further to this, we also 
observed alterations in expression of genes that are involved in nucleotide biosynthesis, which 
mirrors preliminary work by our group, suggesting that sigS may be involved in transcribing the 
genes responsible for de novo assembly of nucleotides (Miller and Shaw, unpublished 
observations).  We also observed changes in expression of a number of different regulators, 
including 3.08 and 3.63 fold decreases in cymR and lacR, respectively; which have both been 
previously shown to negatively influence sigS expression (Burda et al., 2014), suggesting some 
level of reciprocal regulation.  We also identified changes in expression of genes that are 
involved in the oxidative stress response, cell wall metabolism, DNA replication, recombination 
and repair, and virulence, which we have already previously described to both influence sigS 
expression and phenotypes of sigS mutants (Burda et al., 2014), (Miller et al., 2012).  
Discussion.  Bacteria with complex lifestyles or large genomes typically encode multiple ECF 
sigma factors in order to rapidly bring about alterations in gene expression, and adaptation to 
ever-changing environments.  S. aureus is a formidable pathogen that has the ability to infect 
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Figure 9. Genomic map of genes altered upon disruption of ecfY.  The two outer most circles 
represent genes annotated on the forward and reverse strands, respectively.  The dark blue circle 
represents expression values of genes in the wild-type, while the red inner most circle represents 
the expression of genes in the ecfY transposon mutant strain.  The circle in between the red and 
the dark blue depicts a heat map of changes in expression between the two strains.   !  
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Figure 10.  Transcriptomic profiling of ecfY disruption using RNAseq analysis.  Ontological 
grouping of genes altered in expression upon disruption of ecfY, as compared to the parental 
strain. RNA was extracted after 3h growth for both wild-type and mutant. Shown are those genes 
found to be significantly altered in expression at 2-fold or greater. 
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Table 4. Ontology groupings of genes whose expression is influenced by ecfY disruption.  
Ontology Up regulated Down regulated Total 
Metabolism 20 55 75 
Protein Biosynthesis 34 20 54 
Unknown Function 15 35 50 
Transport 20 27 47 
Nucleotide Biosynthesis 10 25 35 
Amino Acid Biosynthesis 7 25 32 
Virulence Associated 7 23 30 
Stress Response 5 23 28 
Regulator 14 13 27 
Membrane Protein 15 9 24 
Cofactor Biosynthesis 2 14 16 
DNA Replication, 
Recombination and Repair 7 6 13 
Phage Protein 8 4 12 
Protease 0 11 11 
Cell Division 4 5 9 
Cell Surface Associated 4 2 6 
Antibiotic Resistance 2 3 5 
Cell Wall Metabolism 1 4 5 
Transcription 3 1 4 
Acetyltransferases 1 2 3 
Lipoprotein 0 1 1 
Total 179 308 487 
! !
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Table 5. Genes with decreased expression upon ecfY disruption. 
Annotation Gene Function Fold Change 
Acetyltransferases 
SAUSA300_2468 
 
Acetyltransferase, GNAT family -3.02 
SAUSA300_1070 
 
Acetyltransferase, GNAT family -2.57 
Amino Acid Biosynthesis 
SAUSA300_1976 
 
Succinyl-diaminopimelate desuccinylase -5.04 
SAUSA300_0325 gcvH Glycine cleavage system H protein -4.80 
SAUSA300_1214 
 
Threonine aldolase -3.65 
SAUSA300_2545 betA Choline dehydrogenase -3.57 
SAUSA300_0360 
 
Cystathionine gamma-synthase -3.22 
SAUSA300_0451 
 
GNAT acetyltransferase -2.91 
SAUSA300_0445 gltB Glutamate synthetase, large subunit -2.86 
SAUSA300_1049 murI Glutamate racemase -2.83 
SAUSA300_2358 
 
ABC-type amino acid transport system, permease component -2.68 
SAUSA300_2404 gltB Glutamate synthase domain 2  -2.61 
SAUSA300_1452 proC Pyrroline-5-carboxylate reductase -2.59 
SAUSA300_2359 
 
Amino acid ABC transporter, amino acid-binding protein -2.56 
SAUSA300_1710 
 
Lysophospholipase -2.48 
SAUSA300_0491 cysK Cysteine synthase -2.45 
SAUSA300_1329 
 
Amino acid permease -2.40 
SAUSA300_2546 betB Glycine betaine aldehyde dehydrogenase -2.35 
SAUSA300_0722 murB UDP-N-acetylenolpyruvoylglucosamine reductase -2.34 
SAUSA300_1560 
 
Hypothetical protein -2.33 
SAUSA300_2251 
 
Dehydrogenase -2.29 
SAUSA300_2281 hutG Formimidoylglutamase -2.19 
SAUSA300_1139 sucD Succinyl-CoA synthetase, alpha-subunit -2.16 
SAUSA300_0185 argJ 
Bifunctional ornithine acetyltransferase/N-acetylglutamate synthase 
protein -2.15 
SAUSA300_2067 glyA Serine hydroxymethyltransferase -2.11 
SAUSA300_0433 cysM Cysteine synthase/cystathionine beta-synthase -2.02 
SAUSA300_0359 metC Cystathionine beta-lyases/cystathionine gamma-synthases -2.01 
Antibiotic Resistance 
SAUSA300_2394 
 
OmdA bacteriocin/AMP protection domain -2.64 
SAUSA300_1328 norB Quinolone resistance protein -2.57 
SAUSA300_2396 pnbA Para-nitrobenzyl esterase -2.17 
Cell Division 
SAUSA300_0438 sle1 N-acetylmuramyl-l-alanine amidase -5.21 
SAUSA300_0361 
 
Putative nucleoid occlusion protein -3.56 
SAUSA300_2353 
 
Addiction System antitoxin (Txe/YoeB family) -3.45 
SAUSA300_1787 
 
HIT family hydrolase.  -2.74 
SAUSA300_2402 
 
Addiction System antitoxin (Txe/YoeB family) -2.29 
Cell Surface Associated 
SAUSA300_0548 sdrE Surface Protein -2.37 
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Table 5 Continued 
Annotation Gene Function Fold Change 
SAUSA300_1370 ebpS Elastin-binding protein ebpS   -2.10 
Cell Wall Metabolism 
SAUSA300_2316 
 
Acetyltransferase, GNAT family -5.56 
SAUSA300_2097 
 
Putative NAD dependent epimerase / oxidoreductase -4.95 
SAUSA300_0739 
 
LysM peptidoglycan binding domain -3.15 
SAUSA300_0955 atl Autolysin -2.14 
Cofactor Biosynthesis 
SAUSA300_2532 panD Aspartate 1-decarboxylase -4.99 
SAUSA300_2225 moaC Molybdenum cofactor biosynthesis protein C -3.79 
SAUSA300_2534 panB 3-methyl-2-oxobutanoate hydroxymethyltransferase -3.78 
SAUSA300_1893 nadE NH(3)-dependent NAD(+) synthetase   -3.75 
SAUSA300_0492 folP Dihydropteroate synthase -3.57 
SAUSA300_1894 
 
Nicotinate phosphoribosyltransferase -3.24 
SAUSA300_0551 
 
GTP cyclohydrolase -3.22 
SAUSA300_0504 pdxS Pyridoxal biosynthesis lyase -2.70 
SAUSA300_0381 nfrA Flavin mononucletoide dependent NADPH oxidase -2.53 
SAUSA300_2344 sirB Uroporphyrinogen III methylase SirB, putative -2.44 
SAUSA300_1703 
 
Rhodanese-Like Domain Protein -2.39 
SAUSA300_2533 panC Pantoate-beta-alanine ligase -2.39 
SAUSA300_1451 
 
Short chain dehydrogenase/reductase -2.13 
SAUSA300_1100 
 
3-demethylubiquinone-9 3-methyltransferase -2.00 
DNA Replication, Recombination and Repair 
SAUSA300_0668 
 
Weak MutS2 domain -5.61 
SAUSA300_2485 ada Methylated-DNA--protein-cysteine methyltransferase -4.08 
SAUSA300_1362 hup HU Histone Like Protein -3.36 
SAUSA300_0097 
 
Superfamily I DNA and RNA helicases and helicase subunits -2.76 
SAUSA300_1573 
 
Holliday junction resolvase-like protein -2.51 
SAUSA300_1045 uvrC Excinuclease ABC subunit C -2.13 
Lipoprotein 
SAUSA300_1440 
 
Lipoprotein -4.06 
SAUSA300_0419 
 
Staphylococcal tandem lipoprotein -3.56 
SAUSA300_0693 saeP Putative lipoprotein -2.43 
SAUSA300_2403 
 
Putative lipoprotein -2.10 
SAUSA300_0992 
 
Putative cell-wall binding lipoprotein -2.04 
Membrane Protein 
SAUSA300_1802 
 
Membrane protein -5.88 
SAUSA300_0108 
 
Myosin-cross-reactive antigen like family -4.27 
SAUSA300_0374 
 
Putative membrane protein -2.97 
SAUSA300_1107 
 
Membrane protein -2.79 
SAUSA300_2286 
 
Membrane protein -2.26 
SAUSA300_2252 
 
Membrane protein -2.19 
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SAUSA300_0341 
 
Membrane protein -2.19 
SAUSA300_2320 
 
Membrane protein -2.00 
Metabolism 
SAUSA300_0151 adhE Alcohol dehydrogenase, iron-containing -11.50 
SAUSA300_0594 adh Alcohol dehydrogenase/acetaldehyde reductase -9.74 
SAUSA300_1044 trx Thioredoxin -7.91 
SAUSA300_2079 fba Fructose-bisphosphate aldolase -6.74 
SAUSA300_0557 
 
Haloacid dehalogenase-like hydrolase -6.70 
SAUSA300_2343 narG Respiratory nitrate reductase, alpha subunit -6.69 
SAUSA300_1874 
 
Nonheme-containing ferritin -6.17 
SAUSA300_1725 
 
Transaldolase -6.15 
SAUSA300_2475 
 
Acyl-CoA thioester hydrolase, YbgC/YbaW family -5.23 
SAUSA300_2346 nirB Nitrite reductase [NAD(P)H], large subunit -4.74 
SAUSA300_2540 
 
Fructose-1,6-bisphosphate aldolase -4.69 
SAUSA300_2492 gat Galactoside O-Acetyltransferase -4.58 
SAUSA300_1258 
 
4-Oxalocrotonate tautomerase -4.39 
SAUSA300_1728 
 
Aldo/keto reductase -4.30 
SAUSA300_0591 
 
GNAT Acetyltransferase -4.25 
SAUSA300_0220 pflB Formate acetyltransferase -4.20 
SAUSA300_0394 
 
FAD/NAD(P)-binding Rossmann fold superfamily -4.19 
SAUSA300_0099 plc Phosphatidylinositol-specific phospholipase -3.86 
SAUSA300_2236 
 
Acyl-CoA dehydrogenase -3.86 
SAUSA300_2537 ldh2 L-lactate dehydrogenase 2 -3.77 
SAUSA300_0556 
 
6-phospho-3-hexuloisomerase -3.59 
SAUSA300_0129 
 
2,3-butanediol dehydrogenase -3.47 
SAUSA300_2593 
 
Flavin reductase/oxidoreductase -3.45 
SAUSA300_1125 acpP Acyl carrier protein -3.16 
SAUSA300_2473 
 
Esterase/Lipase -3.14 
SAUSA300_2525 
 
Fructosamine-3-kinase -3.07 
SAUSA300_0758 tpiA Triosephosphate isomerase -3.07 
SAUSA300_2146 
 
Zn containing alcohol dehydrogenase -3.03 
SAUSA300_0789 
 
Thioredoxin -2.93 
SAUSA300_1901 aldH 4,4′-diaponeurosporen-aldehyde dehydrogenase  -2.89 
SAUSA300_2542 
 
Medium-chain acyl-CoA synthetase -2.85 
SAUSA300_0825 
 
Nitronate monooxygenase -2.85 
SAUSA300_0536 hchA Chaperone -2.84 
SAUSA300_2416 
 
Short chain dehydrogenase -2.82 
SAUSA300_1248 
 
Fe-S cluster assembly scaffold protein -2.71 
SAUSA300_2260 
 
Dual specificity inositol monophosphatase/NADP(H) phosphatase -2.64 
SAUSA300_2317 
 
Quinone oxidoreductase of Zn-dependent oxidoreductase -2.57 
SAUSA300_0965 folD 
Bifunctional 5,10-methylene-tetrahydrofolate dehydrogenase/ 5,10-
methylene-tetrahydrofolate cyclohydrolase -2.53 
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SAUSA300_1804 
 
Glucosamine-6-phosphate isomerase -2.47 
SAUSA300_0841 
 
NADH dehydrogenase, FAD-containing subunit -2.38 
SAUSA300_2462 frp NAD(P)H-flavin oxidoreductase/nitroreductase -2.32 
SAUSA300_2267 
 
Haloacid dehalogenase (HAD) subfamily IA  -2.29 
SAUSA300_0177 
 
Acyl/Butyrl-CoA dehydrogenases -2.27 
SAUSA300_2254 
 
2-hydroxyacid dehydrogenase -2.26 
SAUSA300_1994 scrB Sucrose-6-phosphate hydrolase -2.25 
SAUSA300_2631 
 
Arylamine N-acetyltransferase -2.25 
SAUSA300_0847 
 
Thioesterase superfamily -2.21 
SAUSA300_0873 cdr Coenzyme A disulfide reductase -2.20 
SAUSA300_1081 
 
Multi-copper polyphenol oxidoreductase laccase -2.19 
SAUSA300_0540 
 
HAD hydrolase, family IIIA -2.17 
SAUSA300_0375 
 
Phosphoglycerate mutase -2.14 
SAUSA300_2076 
 
Aldehyde dehydrogenase family protein -2.12 
SAUSA300_2461 
 
Ring-cleavage extradiol dioxygenase -2.11 
SAUSA300_0903 
 
Thioredoxin or dithiol-disulfide isomerase -2.09 
SAUSA300_2500 crtQ 4,4'-diaponeurosporenoate glycoslytransferase -2.04 
Nucleotide Biosynthesis 
SAUSA300_2551 nrdD Anaerobic ribonucleotide reductase, large subunit -5.95 
SAUSA300_2548 
 
Metallo-beta-lactamase superfamily -4.03 
SAUSA300_0747 trxB Thioredoxin reductase  -3.78 
SAUSA300_2518 
 
Alpha/beta hydrolase family -3.76 
SAUSA300_0307 
 
5'-nucleotidase -3.75 
SAUSA300_2550 nrdG Anaerobic ribonucleotide reductase, small subunit -3.65 
SAUSA300_2580 
 
Isochorismatase family of cystine hydrolases-protein -3.28 
SAUSA300_0147 
 
5'-nucleotidase/2',3'-cyclic phosphodiesterase -3.09 
SAUSA300_2439 galU UTP--glucose-1-phosphate uridylyltransferase   -3.00 
SAUSA300_0907 relQ Putative (p)ppGpp synthase domain protein -2.90 
SAUSA300_0517 
 
RNA methyltransferase -2.82 
SAUSA300_0025 
 
UshA like protein -2.79 
SAUSA300_1050 
 
Nucleoside triphosphate -2.63 
SAUSA300_0288 
 
Hypothetical Protein -2.61 
SAUSA300_1151 pyrH Uridylate kinase -2.57 
SAUSA300_2080 
 
Hypothetical Protein -2.50 
SAUSA300_0141 deoB Phosphopentomutase -2.39 
SAUSA300_2066 upp Uracil phosphoribosyltransferase -2.30 
SAUSA300_0516 
 
Ribonuclease III family protein -2.21 
SAUSA300_2243 ureG Urease accesory protein -2.17 
SAUSA300_0459 tmk Thymidylate kinase -2.13 
SAUSA300_2446 relP Putative (p)ppGpp synthase domain protein -2.10 
SAUSA300_1181 
 
Metallophosphoesterase -2.08 
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SAUSA300_2240 ureC Urease, alpha subunit -2.07 
SAUSA300_0905 
 
Triphosphate tunnel metalloenzyme (TTM)-like superfamily -2.02 
Phage Proteins 
SAUSA300_0815 ear Ear Protein -4.96 
SAUSA300_1969 
 
Phage transcriptional repressor  -3.95 
SAUSA300_1861 
 
Phage protein -2.91 
SAUSA300_0579 
 
Phage protein -2.50 
Proteases 
SAUSA300_0372 
 
PepSY/YPEB domain -4.71 
SAUSA300_2486 clpL Endopeptidase Clp ATP-binding regulatory subunit -3.87 
SAUSA300_0105 
 
Putative amidohydrolases -3.65 
SAUSA300_2400 pepA2 Aminopeptidase -3.57 
SAUSA300_1674 htrA1 HtrA1 Serine Protease -3.48 
SAUSA300_0752 clpP ClpP Protease -2.94 
SAUSA300_2087 hmrA HMRA peptidase. -2.85 
SAUSA300_1460 pepT2 Aminopeptidase -2.47 
SAUSA300_1654 pepP1 Proline specific aminopeptidase -2.30 
SAUSA300_1691 pepA1 Aminopeptidase -2.09 
SAUSA300_1905 
 
Predicted choloylglycine hydrolase -2.01 
Protein Biosynthesis 
SAUSA300_1823 
 
tRNA -7.16 
SAUSA300_0447 
 
tRNA -4.36 
SAUSA300_1834 
 
tRNA -4.14 
SAUSA300_0343 
 
Acetyltransferase, GNAT family -3.32 
SAUSA300_0857 prsA2 PrsA-like protein -3.17 
SAUSA300_0943 
 
GNAT acetyltransferase -3.10 
SAUSA300_1813 
 
tRNA -3.09 
SAUSA300_1909 
 
Thioredoxin-type protein -2.89 
SAUSA300_0026 rimH/orfX 
rRNA large subunit methyltransferase, in the SPOUT methyltransferase 
family -2.76 
SAUSA300_1830 
 
tRNA -2.72 
SAUSA300_1833 
 
tRNA -2.72 
SAUSA300_0897 trpS Tryptophanyl-tRNA synthetase -2.68 
SAUSA300_0930 
 
Lipoate-protein ligase A -2.61 
SAUSA300_1365 rpsA 30S ribosomal protein S1 -2.54 
SAUSA300_0522 rplK Ribosomal protein L11 -2.51 
SAUSA300_2074 rpmE 50S ribosomal protein L31 type B -2.37 
SAUSA300_2474 
 
Thioredoxin-type protein -2.29 
SAUSA300_1150 tsf Translation elongation factor Ts -2.27 
SAUSA300_1704 leuS Leucyl tRNA-synthetase -2.19 
SAUSA300_1688 
 
Phenylalanyl-tRNA synthetase (Beta subunit)  -2.01 
Regulators 
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SAUSA300_2347 nirR Nitrite reductase transcriptional regulator -4.40 
SAUSA300_2156 lacR Lactose operon repressor -3.63 
SAUSA300_1639 phoP PhoP response regulator -3.38 
SAUSA300_1583 cymR Cystine metabolism regulator -3.09 
SAUSA300_0255 lytR LytR response regulator -2.87 
SAUSA300_0475 spoVG Sporulation regulatory protein -2.79 
SAUSA300_0373 
 
XRE-family DNA Binding Protein -2.76 
SAUSA300_2338 nreB NreB Histidine Kinase -2.67 
SAUSA300_0655 
 
YebC/PmpR putative transcriptional regulator -2.33 
SAUSA300_0878 
 
LysR Regulator -2.27 
SAUSA300_2625 
 
 PadR family transcriptional regulator -2.19 
SAUSA300_0988 ktrA Potassium transport regulator -2.19 
SAUSA300_1997 
 
SirA-like protein -2.18 
Stress Response 
SAUSA300_0234 hmp Nitric oxide dioxygenase -5.06 
SAUSA300_1652 
 
Universal stress protein -4.68 
SAUSA300_0859 
 
NADH:flavin oxidoreductases -4.28 
SAUSA300_1659 tpx Peroxiredoxin (PRX) family -3.43 
SAUSA300_0816 cbsD CsbD-like superfamily general stress protein -3.27 
SAUSA300_0380 ahpC Alkyl hydroperoxide reductase subunit C -3.11 
SAUSA300_1784 traP Signal transduction protein -3.03 
SAUSA300_0786 
 
Peroxiredoxin/organic hydroperoxide resistance protein -2.86 
SAUSA300_1582 
 
CsbD superfamily -2.75 
SAUSA300_1788 
 
Uncharacterized membrane protein -2.67 
SAUSA300_1513 sodA Superoxide dismutase -2.63 
SAUSA300_1463 
 
Disulphide isomerase -2.61 
SAUSA300_0508 mcsA Metal ion stress protein -2.46 
SAUSA300_0338 
 
Glyoxalase family protein -2.40 
SAUSA300_1856 pfpI PfpI intracellular protease -2.39 
SAUSA300_0362 
 
Putative mechanosensitive channel protein -2.25 
SAUSA300_2092 dps General stress protein 20U -2.20 
SAUSA300_0790 
 
Putative arsenate reductase -2.19 
SAUSA300_0135 sodM Superoxide dismutase -2.07 
SAUSA300_0484 
 
Ribosome-associated heat shock protein -2.06 
SAUSA300_2327 
 
 Pyridoxamine 5'-phosphate oxidase family protein -2.05 
SAUSA300_0486 
 
S1 RNA Binding Domain Protein -2.01 
SAUSA300_0569 hemQ Heme peroxidase -2.01 
Transcription 
SAUSA300_1103 rpoZ RNAP omega subunit -4.30 
Transport 
SAUSA300_0173 
 
Dipeptide/oligopeptide/nickel ABC transporter permease -5.40 
! 69!
Table 5 Continued 
Annotation Gene Function Fold Change 
SAUSA300_2628 rarD Transporter -4.87 
SAUSA300_2333 narK Nitrite extrusion protein -4.64 
SAUSA300_0676 
 
Divalent Anion:Na+ Symporter  -4.12 
SAUSA300_2472 
 
EamA family transporter -3.85 
SAUSA300_0176 
 
ABC transporter, permease protein -3.73 
SAUSA300_0344 fepA Iron-transport system -3.61 
SAUSA300_2479 cidA Holin-like protein -3.13 
SAUSA300_0232 
 
Putative uroporphyrin-III C-methyltransferase -2.90 
SAUSA300_0345 fepB Iron-transport system -2.88 
SAUSA300_2557 nsaA ABC transporter protein -2.86 
SAUSA300_0796 
 
ABC-type transport system, ATPase component -2.79 
SAUSA300_0174 
 
Nitrate sulfonate taurine bicarbonate transport system ATPase component  -2.78 
SAUSA300_2393 opuCA Glycine betaine/carnitine/choline ABC transporter ATP-binding protein -2.77 
SAUSA300_0175 
 
ABC transporter, substrate-binding protein -2.63 
SAUSA300_2399 
 
ABC-type uncharacterized transport system, ATPase component -2.63 
SAUSA300_2627 
 
Divalent Anion:Na+ Symporter -2.60 
SAUSA300_2552 
 
Citrate transporter -2.58 
SAUSA300_0115 sirC Iron compound ABC transporter, permease protein  -2.56 
SAUSA300_0236 
 
PTS system, IIBC component -2.22 
SAUSA300_0824 corB Magnesium and cobalty efflux protein -2.20 
SAUSA300_1676 sgtA Monofunctional transglycosylase -2.18 
SAUSA300_2398 
 
ABC-type uncharacterized transport system, permease component -2.17 
SAUSA300_0309 
 
ABC transporter ATP-Binding protein -2.14 
SAUSA300_1998 
 
Possible selenium or sulfur transporter -2.10 
SAUSA300_0382 
 
Na+/dicarboxylate symporter -2.10 
SAUSA300_1029 isdA Cell wall anchored hemoglobin binding protein -2.02 
Unknown Function 
SAUSA300_0768 
 
Unknown -9.50 
SAUSA300_1747 
 
Unknown -4.65 
SAUSA300_0740 
 
Unknown -4.26 
SAUSA300_0567 
 
Unknown -4.25 
SAUSA300_1012 
 
Unknown -4.22 
SAUSA300_1574 
 
Unknown -4.08 
SAUSA300_0409 
 
Unknown -4.06 
SAUSA300_0940 
 
Unknown -3.98 
SAUSA300_2093 
 
Unknown -3.81 
SAUSA300_2592 
 
Unknown -3.79 
SAUSA300_2641 
 
Unknown -3.61 
SAUSA300_0657 
 
Unknown -3.60 
SAUSA300_2531 
 
Unknown -3.56 
 
! 70!
Table 5 Continued 
Annotation Gene Function Fold Change 
SAUSA300_0842 
 
Unknown -3.13 
SAUSA300_0294 
 
Unknown -2.96 
SAUSA300_0460 
 
Unknown -2.90 
SAUSA300_0421 
 
Unknown -2.68 
SAUSA300_0793 
 
Unknown -2.60 
SAUSA300_0339 
 
Unknown -2.45 
SAUSA300_2005 
 
Unknown -2.43 
SAUSA300_0383 
 
Unknown -2.38 
SAUSA300_2068 
 
Unknown -2.30 
SAUSA300_0041 
 
Unknown -2.27 
SAUSA300_2053 ywpF Unknown -2.26 
SAUSA300_0602 
 
Unknown -2.25 
SAUSA300_0767 
 
Unknown -2.24 
SAUSA300_1439 
 
Unknown -2.23 
SAUSA300_0931 
 
Unknown -2.18 
SAUSA300_0287 
 
Unknown -2.12 
SAUSA300_0035 
 
Unknown -2.11 
SAUSA300_0595 
 
Unknown -2.05 
SAUSA300_2544 
 
Unknown -2.05 
SAUSA300_1898 
 
Unknown -2.04 
SAUSA300_1240 
 
Unknown -2.03 
SAUSA300_1665 
 
Unknown -2.02 
Virulence Associated 
SAUSA300_0883 eapH2 Eap/Map protein -19.72 
SAUSA300_1382 lukS-PV Panton-Valentine leukocidin, LukS-PV -13.54 
SAUSA300_1381 lukF-PV Panton-Valentine leukocidin, LukF-PV -12.17 
SAUSA300_0951 sspA V8 protease -6.79 
SAUSA300_1918 hlb Truncated beta-hemolysin -5.36 
SAUSA300_2441 fnbpA Fibronectin binding protein A -4.95 
SAUSA300_2572 aur Zinc metalloproteinase aureolysin -4.88 
SAUSA300_0950 sspB Staphopain B -4.71 
SAUSA300_1758 splA Serine protease SplA -4.58 
SAUSA300_2435 
 
SasG protein -3.80 
SAUSA300_2367 hlgB Gamma-hemolysin component B -3.53 
SAUSA300_0285 esxB EsxB -3.48 
SAUSA300_1754 splE Serine protease SplE -3.27 
SAUSA300_1756 splC Serine protease SplC -2.89 
SAUSA300_1768 lukD Leukotoxin LukD -2.77 
SAUSA300_0949 sspC Staphostatin B -2.56 
SAUSA300_1753 splF Serine protease SplF -2.55 
SAUSA300_1919 scinA Staph complement inhibitory protein A -2.46 
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SAUSA300_2164 eapH1 MAP/EAP domain protein -2.43 
SAUSA300_2366 hlgC Gamma-hemolysin component C -2.29 
SAUSA300_1757 splB Serine protease SplB -2.16 
SAUSA300_0370 selX Staphylococcal enterotoxin-like toxin X -2.15 
SAUSA300_1755 splD Serine protease SplD -2.04 
 ! !
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Aceytletransferases 
SAUSA300_0643 
 
GNAT Acetyltransferase 2.08 
Amino Acid Biosynthesis 
SAUSA300_1225 
 
Aspartate kinase 3.28 
SAUSA300_1046 sdhC Succinate dehydrogenase, cytochrome b-558 subunit 2.88 
SAUSA300_1686 murC UDP-N-acetylmuramate-alanine ligase 2.56 
SAUSA300_0184 argB Acetylglutamate kinase 2.42 
SAUSA300_1465 
 
2-oxoglutarate dehydrogenase subunit E1, beta subunit 2.23 
SAUSA300_0478 prs Ribose-phosphate pyrophosphokinase 2.09 
SAUSA300_0458 ldcC Arginine/lysine/ornithine decarboxylases 2.01 
Antibiotic Resistance 
SAUSA300_0648 vraG Drug ABC transporter 5.29 
SAUSA300_2128 sdrM Multi-drug resistance transporter 2.26 
Cell Division 
SAUSA300_1072 mraZ Cell division protein 4.71 
SAUSA300_1337 gpsB Cell division protein 4.64 
SAUSA300_1445 scpA Segregation and condensation protein A 2.72 
SAUSA300_1444 scpB Chromosome segregation and condensation protein B 2.30 
Cell Surface Associated 
SAUSA300_1257 
 
LytR-CpsA-Psr family protein 3.08 
SAUSA300_2130 
 
UTP-glucose-1-phosphate uridylyltransferase 2.97 
SAUSA300_2586 asp2 Secondary Sec system accessory secretory protein 2.12 
SAUSA300_2582 gtfB GT1 glycosyltransferase - modifies SraP 2.02 
Cell Wall Metabolism 
SAUSA300_1076 mraY Phospho-N-acetylmuramoyl-pentapeptide-transferase 2.06 
DNA Replication, Recombination and Repair 
SAUSA300_1251 parC DNA topoisomerase IV, A subunit 2.94 
SAUSA300_1346 dnaQ DnaQ family exonuclease/DinG family helicase 2.87 
SAUSA300_1522 dnaG DNA primase 2.67 
SAUSA300_1592 recJ Single-stranded-DNA-specific exonuclease 2.63 
SAUSA300_0367 ssb single-strand binding protein 2.33 
SAUSA300_1876 
 
DNA polymerase IV 2.08 
SAUSA300_1472 xseA Exodeoxyribonuclease VII, large subunit 2.01 
Membrane Protein 
SAUSA300_2448 
 
Putative membane protein 5.88 
SAUSA300_1352 
 
Putative membane protein 3.54 
SAUSA300_2131 
 
Putative membane protein 3.29 
SAUSA300_2095 
 
Membrane protein 3.23 
SAUSA300_1241 
 
Membrane protein 3.23 
SAUSA300_0582 
 
Hypothetical Membrane Protein 3.14 
SAUSA300_1017 
 
Membrane protein 2.82 
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SAUSA300_0694 
 
Hypothetical Membrane Protein 2.71 
SAUSA300_0640 
 
Membrane protein 2.61 
SAUSA300_2046 
 
Putative membane protein 2.52 
SAUSA300_2297 
 
Hypothetical Membrane Protein 2.52 
SAUSA300_0678 
 
Membrane protein 2.37 
SAUSA300_1877 
 
Membrane protein 2.33 
SAUSA300_0603 
 
Putative membane protein 2.21 
SAUSA300_0729 
 
Membrane protein 2.11 
Metabolism 
SAUSA300_1247 
 
Putative thioesterase 5.03 
SAUSA300_1456 
 
Alpha-D-1,4-glucosidase 4.42 
SAUSA300_2443 gntK Gluconate kinase 3.02 
SAUSA300_2064 atpB ATP synthase F0 subunit A 2.79 
SAUSA300_0538 
 
L-threonine dehydrogenase 2.62 
SAUSA300_1154 cdsA Phosphatidate cytidylyltransferase 2.61 
SAUSA300_1069 
 
Haloacid dehalogenase-like hydrolase 2.58 
SAUSA300_1550 
 
Methyltransferase 2.39 
SAUSA300_2529 phnB Putative 3-demethylubiquinone-9 3-methyltransferase 2.35 
SAUSA300_1124 fabG 3-oxoacyl-(acyl-carrier-protein) reductase 2.35 
SAUSA300_1310 
 
Phosphatidic acid phosphatase/phospholipid phosphatase 2.32 
SAUSA300_0627 tagX Glycosyltransferase  2.30 
SAUSA300_1015 ctaA Cytochrome oxidase assembly protein 2.23 
SAUSA300_2057 atpC ATP synthase F1 epsilon subunit 2.15 
SAUSA300_1616 hemD Uroporphyrinogen-III synthase 2.13 
SAUSA300_0788 
 
Nitroreductase 2.13 
SAUSA300_2499 crtM 4,4′-diapophytoene synthase 2.10 
SAUSA300_1123 fabD Malonyl CoA-acyl carrier protein transacylase 2.08 
SAUSA300_0874 
 
Putative hydrolase 2.08 
SAUSA300_1618 hemX Cytochrome C assembly protein 2.05 
Cofactor Biosynthesis 
SAUSA300_0944 menA 1,4-dihydroxy-2-naphthoate octaprenyltransferase 2.93 
SAUSA300_1872 cobQ Cobyric acid synthase 2.44 
Nucleotide Biosynthesis 
SAUSA300_2073 tdk Thymidine kinase 3.39 
SAUSA300_2303 tcaR TcaR 2.71 
SAUSA300_0488 
 
Hypoxanthine phosphoribosyltransferase 2.63 
SAUSA300_0974 purN Phosphoribosylglycinamide formyltransferase 2.49 
SAUSA300_0973 purM Phosphoribosylformylglycinamidine cyclo-ligase 2.42 
SAUSA300_0968 purC Phosphoribosylaminoimidazole-succinocarboxamide synthase 2.33 
SAUSA300_1091 pyrR Bifunctional pyrimidine regulatory protein PyrR/uracil phosphoribosyltransferase 2.23 
SAUSA300_0386 xpt Xanthine phosphoribosyltransferase 2.19 
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SAUSA300_1358 ndk Nucleoside diphosphate kinase 2.09 
SAUSA300_0975 purH Bifunctional purine biosynthesis protein 2.01 
Phage Proteins 
SAUSA300_0814 
 
Abortive infection bacteriophage resistance protein 3.87 
SAUSA300_2506 isaA Immunodominant staphylococcal antigen A 3.79 
SAUSA300_1961 
 
PhiPVL ORF41-like protein 2.72 
SAUSA300_1432 
 
PhiSLT ORF78-like protein  2.69 
SAUSA300_1965 
 
Hypothetical protein  2.69 
SAUSA300_1437 
 
PhiSLT ORF204-like protein  2.55 
SAUSA300_1921 
 
Truncated amidase 2.37 
SAUSA300_2578 
 
YhgE/Pip 2.11 
Protein Biosynthesis 
SAUSA300_0529 
 
Ribosomal L7Ae superfamily 7.27 
SAUSA300_0932 
 
CAA-X Processing Protease 5.57 
SAUSA300_1817 
 
tRNA 5.06 
SAUSA300_1776 
 
tRNA 4.52 
SAUSA300_0523 rplA Ribosomal protein L1 3.75 
SAUSA300_0524 rplJ 50S ribosomal protein L10 3.66 
SAUSA300_0916 
 
RNA ligase or phosphoesterase 3.62 
SAUSA300_0530 rpsL 30S ribosomal protein S12 3.44 
SAUSA300_0366 
 
Ribosomal protein S6 3.21 
SAUSA300_1694 
 
tRNA (guanine-N(7)-)-methyltransferase 3.04 
SAUSA300_2603 
 
Triacylglycerol lipase  3.02 
SAUSA300_1163 rbfA Ribosome binding factor 2.93 
SAUSA300_0926 
 
tRNA 2.90 
SAUSA300_1772 
 
tRNA 2.82 
SAUSA300_0532 fusA Translation elongation factor G 2.71 
SAUSA300_2190 rpsH 30S ribosomal protein S8 2.68 
SAUSA300_0531 
 
30S ribosomal protein S7 2.58 
SAUSA300_1622 tig Trigger Factor 2.58 
SAUSA300_1602 
 
Putative ribosomal protein? 2.57 
SAUSA300_1348 
 
tRNA CCA-pyrophosphorylase 2.56 
SAUSA300_1832 
 
tRNA 2.56 
SAUSA300_1161 
 
Ribosomal L7Ae superfamily 2.53 
SAUSA300_2202 rplW 50S ribosomal protein L23 2.51 
SAUSA300_0181 
 
Nonribosomal peptide synthetases 2.47 
SAUSA300_2072 
 
Peptide chain release factor 1 2.46 
SAUSA300_2071 
 
Protein-glutamine methyltransferase 2.36 
SAUSA300_1595 tgt Queuine tRNA-ribosyltransferase 2.32 
SAUSA300_1831 
 
tRNA 2.27 
SAUSA300_1364 engA Ribosome-associated GTPase 2.22 
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Table 6.  Continued 
Annotation Gene Function Fold Change 
SAUSA300_2185 rplO 50S ribosomal protein L15 2.21 
SAUSA300_2192 rplE 50S ribosomal protein L5 2.19 
SAUSA300_1066 
 
tRNA 2.18 
SAUSA300_2172 rplM 50S ribosomal protein L13 2.04 
SAUSA300_1443 rluB Ribosomal large subunit pseudouridine synthase B 2.02 
Regulators 
SAUSA300_0928 comK Regulator of competence 3.97 
SAUSA300_2322 
 
TetR transcriptional regulator 3.69 
SAUSA300_0653 rbf Regulator of biofilm 3.46 
SAUSA300_1797 xdrA Xre regulator 3.29 
SAUSA300_1809 
 
Putative toxin regulator 3.20 
SAUSA300_1888 
 
TrpR homolog 3.17 
SAUSA300_2559 nsaR NsaR response regulator 2.91 
SAUSA300_1237 lexA LexA repressor 2.63 
SAUSA300_0683 
 
Fructose operon repressor 2.55 
SAUSA300_0898 spxA Regulatory protein spx 2.30 
SAUSA300_1995 scrR Sucrose operon repressor 2.15 
SAUSA300_1190 glpP Glycerol uptake operon antiterminator regulatory protein 2.09 
SAUSA300_0022 yycH YycH protein 2.00 
Stress Response 
SAUSA300_2639 cspD Cold shock protein D 15.28 
SAUSA300_0777 cspC Cold shock protein C 3.92 
SAUSA300_2332 
 
Heat shock protein 2.47 
SAUSA300_1474 
 
Asp23 superfamily; alkaline shock protein 2.38 
SAUSA300_2024 rsbV Anti-sigma factor 2.27 
Transcription 
SAUSA300_2037 srmB Superfamily II DNA and RNA helicases 5.41 
SAUSA300_1160 
 
Transcription terminator 4.32 
SAUSA300_1722 sigS ECF family sigma factor 2.08 
Transport 
SAUSA300_1374 
 
Hypothetical riboflavin transporter 10.38 
SAUSA300_2324 
 
PTS system, sucrose-specific IIBC component 8.23 
SAUSA300_0448 treP PTS system, trehalose-specific IIBC component 5.18 
SAUSA300_1245 opuD Glycine betaine transporter 4.35 
SAUSA300_2449 
 
MFS transporter 3.76 
SAUSA300_0850 mnhF Monovalent cation/H+ antiporter subunit F 3.40 
SAUSA300_0625 tagG Teichoic acids export protein permease protein 3.40 
SAUSA300_0849 mnhG Monovalent cation/H+ antiporter subunit G 3.16 
SAUSA300_0977 
 
ABC-type cobalt  transport system, permease component 3.10 
SAUSA300_0649 
 
PhoU transporter 2.71 
SAUSA300_2207 pbuG? Xanthine/uracil/vitamin C permease family protein 2.69 
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Table 6.  Continued 
Annotation Gene Function Fold Change 
SAUSA300_0978 
 
ABC-type cobalt transport system, ATP-binding component 2.68 
SAUSA300_0633 
 
Iron compound ABC transporter, ATP-binding protein 2.44 
SAUSA300_1285 
 
ABC transporter 2.32 
SAUSA300_2323 
 
Magnesium transporter 2.28 
SAUSA300_0853 mnhC Monovalent cation/H+ antiporter subunit C 2.22 
SAUSA300_0670 cydD ABC-type transport system, cytochrome bd, cystine, glutathione 2.18 
SAUSA300_1913 pmtA PSM essential transporter 2.09 
SAUSA300_0650 
 
Inorganic phosphate transporter 2.08 
SAUSA300_1252 
 
Na+/alanine symporter 2.02 
Unknown Function 
SAUSA300_2212 
 
Unknown 5.79 
SAUSA300_0781 
 
Unknown 4.07 
SAUSA300_1739 
 
Unknown 3.96 
SAUSA300_0957 
 
Unknown 3.49 
SAUSA300_0642 
 
Unknown 2.97 
SAUSA300_0639 
 
Unknown 2.88 
SAUSA300_1904 
 
Unknown 2.86 
SAUSA300_0826 
 
Unknown 2.83 
SAUSA300_1353 
 
Unknown 2.80 
SAUSA300_1789 
 
Unknown 2.41 
SAUSA300_2620 
 
Unknown 2.35 
SAUSA300_1577 
 
Unknown 2.29 
SAUSA300_1372 
 
Unknown 2.22 
SAUSA300_1011 
 
Unknown 2.15 
SAUSA300_1010 
 
Unknown 2.01 
Virulence Associated 
SAUSA300_1989 agrB Accessory gene regulator protein B 2.98 
SAUSA300_1992 agrA Accessory gene regulator protein A 2.44 
SAUSA300_1101 
 
Fibronectin-binding protein 2.43 
SAUSA300_1052 ehb Ehb complement inhibitory protein 2.30 
SAUSA300_1990 agrD Accessory gene regulator protein D 2.24 
SAUSA300_2565 clfB Clumping factor B 2.14 
SAUSA300_0801 seq Enterotoxin Q 2.05 
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every ecological niche of the human body.  With such a complex lifestyle it would be 
unsurprising if the genome of S. aureus encoded a multitude of ECF sigma factors in order to 
facilitate infection.  However, to date only one (σS) has been described (Shaw et al., 2008). 
It is a hallmark of ECF sigma factors to be transcriptionally linked to a gene encoding a 
transmembrane anti-sigma factor that prevents the sigma factor from associating with core-
RNAP (Helmann, 1999), (Hughes & Mathee, 1998).  We demonstrate herein that the sigS locus 
is tightly conserved amongst the staphylococci, and consists only of σS, and three other genes. 
When looking at the down stream gene, ecfX, it does appear to be transcriptionally linked to sigS 
but does not contain any transmembrane domains.  With that said, cytoplasmic anti-sigma factors 
have been described, such as RsrA, which regulates the ECF sigma factor σR of S. coelicolor 
(Kang et al., 1999).  When we evaluated the effect of a mutation in ecfX, we unexpectedly 
observed a significant decrease in sigS expression, rather than the typical increase demonstrated 
by anti-sigma factor inactivation in other organisms (Helmann, 1999), (Hughes & Mathee, 
1998), (Schurr, Yu, Martinez-Salazar, Boucher, & Deretic, 1996). Curiously, we observed that in 
an archaic staphylococcal strain, S. carnosus, the sigS and ecfX genes are annotated as a single 
open reading frame that encodes one protein.  Therefore, we hypothesize that the sigS and ecfX 
genes may have arisen as a single unit that has since diverged into two separate genes/proteins, 
but that may still function together.  In order to confirm this, we performed protein pull down 
assays with purified σS and EcfX and found that these two proteins do in fact interact with each 
other.  Thus, these results would suggest that σS and EcfX may function together in order to bring 
about changes in gene expression in response to stress.  This is supported, at least in part, by the 
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observation that EcfX possesses a ComK domain, which has been shown to bind DNA and 
regulate gene expression in a number of other organisms. 
Downstream of ecfX in the conserved sigS cluster is ecfY, which specifies a protein predicted to 
have 2 transmembrane domains: thus making it a more likely candidate to serve as an anti-sigma 
factor. Interestingly, RNAseq analysis revealed that the majority of transcription in the sigS locus 
actually arises from an extended ecfY 3’ UTR that continues to run through ecfX and sigS.  In 
order to determine if this is the reason for the low levels of sigS and ecfX expression we have 
previously observed (Miller et al., 2012), (Shaw et al., 2008), we performed qPCR analysis on a 
strain lacking the ecfY transcript, and found a significant increase in both sigS and ecfX 
expression. Classically, ECF sigma factors are regulated by an anti-sigma factor through protein-
protein interaction (Helmann, 1999).  However, our work suggests that sigS is being regulated by 
ecfY through RNA-RNA interaction of the extended 3’ end of the ecfY transcript.  To validate 
this hypothesis, we constructed two ecfY complement strains that contain either the coding region 
of ecfY alone (ecfY-S), or the coding region and the extended 3’ UTR (ecfY-L).  Importantly, we 
found that only the ecfY-L complement was able to suppress sigS and ecfX transcription, 
indicating that it is the ecfY extended 3’ UTR, rather than the EcfY protein that is responsible for 
the low level of expression of these two genes.  
We have previously shown that sigS mutants of S. aureus have impaired survival upon challenge 
with H2O2, ethidium bromide, and MMS (Miller et al., 2012). Given that the ecfY disrupted strain 
displays enhanced sigS expression we hypothesized that this mutant may display increased 
survival in response to these situations compared not only to a sigS mutant, but the parental 
strain as well. Upon analysis we did indeed observe these effects, with the ecfY knock-down 
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strain proving better able to survive oxidative and DNA damage stress compared to the wild-
type. We again used our complementation constructs to explore these findings further, 
hypothesizing that if EcfY was regulating σS via protein-protein interaction, we would be able to 
complement our phenotypes with both complement strains.  Conversely, if the regulation was 
occurring through RNA-RNA interaction, then we would only be able to complement our 
experiments with the ecfY coding region and extended 3’ UTR.  We determined that 
complementation of these phenotypes was only possible for the construct containing ecfY and the 
extended 3’ UTR, which again indicates that ecfY is regulating sigS through RNA-RNA 
interaction.   
The opposing phenotypes described herein are not uncommon when the negative regulator of an 
ECF sigma factor is disrupted.  Indeed, when MucA, the anti-sigma factor of AlgU, is mutated in 
the opportunistic pathogen, P. aeruginosa, this leads to an increase in this organisms ability to 
survive phagocytosis by human leukocytes (Schurr et al., 1996), (Schwarzmann & Boring, 
1971).  Additionally, CarQ is an ECF sigma factor in the Gram-negative organism Myxococcus 
xanthus that controls carotenoid biosynthesis. This leads to protection against reactive oxygen 
species (ROS) produced in response to light (Galbis-Martinez et al., 2008).  Inactivation of the 
cognate anti-sigma factor, CarR, results in increased resistance to photolysis in Myxococcus 
xanthus strains (Burchard & Dworkin, 1966), (McGowan, Gorham, & Hodgson, 1993),. A 
consideration with these examples is that they each are the result of ECF-sigma factor repression 
at the protein level, however we show herein that regulation of σS expression/activity is 
seemingly occurring via RNA-RNA interaction, which has not been described in ECF sigma 
factors biology to date. Such approaches have been demonstrated for the stationary phase sigma 
factor σS in E. coli (despite sharing the same name, these two proteins are not functional 
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homologs) (Hammerle, Vecerek, Resch, & Blasi, 2013), (Soper & Woodson, 2008). Specifically, 
the σS encoding transcript (rpoS) forms a stem-loop secondary structure that sequesters its own 
ribosomal binding site, and thereby inhibits translation (Soper & Woodson, 2008).  At low 
temperatures, the small regulatory RNAs DsrA and RprA interact with rpoS to open this 
inhibitory stem-loop structure and facilitate translation (Brown & Elliott, 1997), (Majdalani, 
Chen, Murrow, St John, & Gottesman, 2001; Majdalani, Cunning, Sledjeski, Elliott, & 
Gottesman, 1998).  As such, there is precedence for RNA-based regulation of sigma factor 
activity in the literature, although as yet, not for those from the ECF family. 
Any attempts to explore the σS regulon have thus far been confounded by a lack of sigS 
expression under standard conditions, and an inability to generate a sigS overexpressing strain 
(likely due to inhibition by the ecfY transcript’s 3’ UTR). Given that we demonstrate sigS 
overexpression in the ecfY null strain, we consequently used it in RNAseq analysis so as to 
identify σS controlled genes.  In so doing, we identified a decrease in the expression of cymR and 
lacR, which we have previously demonstrated to negatively regulate sigS expression (Burda et 
al., 2014).  CymR encodes the master regulator of cysteine biosynthesis in S. aureus (Soutourina 
et al., 2010; Soutourina et al., 2009), and has been previously implicated in the response to 
oxidative damage in S. aureus (Soutourina et al., 2010; Soutourina et al., 2009).  Importantly, 
there was also a decrease in expression for several genes in the ecfY knock-downs strain that 
have previously been shown to be directly regulated by CymR, such as the trx, cysK, cysM, 
ahpC, sodM and sodA.  We have previously shown that sigS expression is induced during 
oxidative stress, and sigS mutants are more sensitive to ROS, whereas our sigS over-expressing 
strrain (the ecfY null strain) is more resistant to this type of damage (Burda et al., 2014). As such, 
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these results indicate a reciprocal relationship of regulation likely exists between CymR and σS 
that strongly influences with response of S. aureus to ROS mediated stress. 
We also identified alterations in expression of ahpC, which encodes an alkyl hydroperoxide 
reductase.  The AhpC enzyme is responsible for scavenging H2O2 in S. aureus, and mutants that 
lack the ahpC gene have been shown to be more resistant when exposed to this agent (Cosgrove 
et al., 2007).  Accordingly, the decrease in expression of this gene goes some way towards 
explaining the increase in resistance of the ecfY null strain to H2O2, likely via sigS 
overexpression.   
We also observed major changes in expression of genes involved in the de novo assembly of 
nucleotides: purC (phosphoribosylaminoimidazol-succinocarboxamide synthase), purH 
(bifunctional purine biosynthesis gene), purM (phosphoribosylformylglycinamidine clyclo-
ligase), purN (phosphoriobylglycinamide formyltransferase), pyrH (bifunctional pyrimidine 
regulatory protein/uracil phosphoribosyltransferase) and tdk (thymidine kinase), which were all 
strongly upregulated in the ecfY knock-down strain.  Interestingly, we have previously identified 
the expression and activity of genes that are involved in purine biosynthesis as being positively 
influence by σS in strain RN4220 Miller and Shaw, unpublished observation. We suggest that 
these findings may, at least in part, explain the sensitivity of sigS mutants (and resistance of ecfY 
mutants) to DNA damage, as previous studies have shown the vital importance of de novo 
nucleotide synthesis for surviving this type of stress (Valentino et al., 2014). Furthermore, recent 
studies have demonstrated that the de novo assembly of purines is vital to pathogenesis in S. 
aureus, E. coli, S. enterica, and B. anthracis (McFarland & Stocker, 1987), (Mei, Nourbakhsh, 
Ford, & Holden, 1997), (Samant et al., 2008), (Valentino et al., 2014). Therefore, it is plausible 
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that the attenuation of virulence observed for the sigS mutant strains may be due to depleted 
purine pools in vivo (Shaw et al., 2008). 
We also identified increased expression of other genes in the ecfY transposon mutant that are 
involved in DNA replication, recombination and repair.  Specifically we noted an increase in 
expression of recJ, which encodes a single-stranded DNA-specific exonuclease.  In E. coli, it has 
been shown that recJ is responsible for degrading single stranded DNA as part of the 
recombination repair pathway in response to damage such as that caused by UV irradiation 
(Lovett & Kolodner, 1989).  In addition, we also observed an increase in the ecfY null strain in 
the expression of xseA, which encodes exodeoxyribonuclease VII.  In E. coli is has been 
demonstrated that xseA is a part of the recombination repair pathway and is involved in 
degrading DNA when exposed to UV irradiation (Repar, Briski, Buljubasic, Zahradka, & 
Zahradka, 2013).  As such, the resistance to UV irradiation demonstrated by the ecfY null strain, 
and sensitivity of sigS mutants to this same stress, may be explained by σS mediated control of 
the recombination repair pathway. 
Previously our group has shown that sigS expression is upregulated by growth in amino acid 
limiting media, and by the disruption of genes involved in the biosynthesis of amino acids 
(Burda et al., 2014), (Miller et al., 2012).  In connection with this, we observed increased 
expression of genes that are involved amino acid biosynthesis in the ecfY transposon mutant. 
This included argB (acetylglutamate kinase), which catalyzes the conversion of N-acetyl-L-
glutamate to N-acetyl-L-glutamate phosphate in the second step of arginine biosynthesis, which 
can be used to synthesize other amino acids, including proline (Cunin, Glansdorff, Pierard, & 
Stalon, 1986), (Townsend, Kaenjak, Jayaswal, & Wilkinson, 1996). It also included prs (ribose-
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phosphate pyrophosphokinase), which is responsible for catalyzing the addition of a 
pyrophosphoryl group to ribose-5-phosphate, generating phosphoribosyl diphosphate (PRPP), a 
key intermediate in the biosynthesis of amino acids, purines and pyrimidines (Hove-Jensen, 
1985).  In B. subtilis, upregulation of prs leads to an increase in PRPP pools inside the cell, 
which in turn leads to an increase in free amino acids, and more importantly, nucleotides (Zhu, 
Yang, Yuan, & Ban, 2015).  Our observation that prs is increased in an ecfY null strain may lead 
to such increase in PRPP, and explain why this strain is more resistant to DNA damaging, while 
a sigS mutant is more sensitive. As such, this would appear to connect the upregulation of sigS in 
response to amino acids starvation, and the role of σS in de novo nucleotide biosynthesis. 
Our previous works have also demonstrated that expression of sigS is induced upon exposure to 
cell wall targeting antibiotics, and that a sigS mutant is more sensitive when exposed such 
agents.  RNAseq analysis reveals that in the ecfY null strain there is an increase in expression of 
mraY, which encodes a phospho-N-acetylmuramoyl-pentapeptie-transferase that catalyzes the 
initial step of peptidoglycan biosynthesis. In B. subtilis, overexpression of mraY leads to an 
increase in MIC for a number of cell wall targeting antibiotics (Ishizaki et al., 2013).  Thus it 
follows that mraY levels in a sigS mutant would be decreased, resulting in the observed 
sensitivity to cell-wall targeting antibiotics.  Conversely, we identified a decrease in expression 
for atl: the major autolysin of S. aureus, in the ecfY transposon mutant (Foster, 1995).  This 
autolysin is involved in cell wall turn over, contributing to the separation of daughter cells 
following cell division, and to antibiotic induced lysis (Biswas et al., 2006), (Foster, 1995), 
(Sugai et al., 1997).  We have previously demonstrated that sigS expression in induced following 
exposure to sodium dodecyl sulfate (SDS) and that sigS mutants are more susceptible to lysis by 
Triton X-100 (Miller et al., 2012).  These results suggest that σS may be responsible for the 
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transcription of genes that are involved in cell wall biosynthesis in response to stress, while 
indirectly repressing the transcription of genes that are involved in the degradation of the cell 
wall. 
Finally, reports by our group have demonstrated that sigS expression is important in the 
virulence of S. aureus using both ex vivo and in vivo models of infection (Miller et al., 2012), 
(Shaw et al., 2008).  We describe here that an ecfY null strain is more resistant to phagocyte 
mediated killing when compared to the sigS mutant and wild-type strain, suggesting that σS 
influences the expression of genes central to the virulence process.  Importantly, in this study we 
observed an increase in expression in the ecfY knock-down strain of the accessory gene regulator 
locus, agr, which encodes a two-component quorum sensing system that is vital to virulence in S. 
aureus (Morfeldt, Janzou, Arvidson, & L fdahl, 1988), (Peng, Novick, Kreiswirth, Kornblum, 
& Schlievert, 1988). Given that sigS is strongly over-expressed upon loss of the ecfY transcript, it 
follows that σS may have some regulatory influence on the expression of agr, explaining the 
virulence attenuation of sigS mutants.  Additionally, RNAseq analysis also revealed an increase 
in expression of a putative fibronectin binding protein (SAUSA300_1101), which has been 
shown to be important in virulence.  Additionally, we observed increase in expression of a 
fibrinogen binding protein, clumping factor B.  Previous studies have indicated that fibrinogen 
mediated adherences is crucial in virulence using a rabbit model of endocarditis (Moreillon et al., 
1995).  Because of the importance to fibronectin binding during infection, the increase in 
expression of these two genes indicates σS contributes to the ability S. aureus to establish an 
infection, as we have already demonstrate its importance in the virulence of this pathogen.  Our 
observation that in the absence of ecfY leads to an increase in sigS expression and in resistances 
to components of the innate immune response, coupled with what appears to be σS- mediated 
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control of virulence associated gene indicates that sigS is important in both the establishment and 
continuation of infection. 
Herein, we present evidence of a unique occurrence whereby and ECF-sigma factor (σS) and a 
putative DNA binding protein (EcfX) seemingly arose as a single transcriptional unit, and thus 
protein, but have since diverged evolutionarily; yet still interact and seemingly function together 
to bring about changes in gene expression.  Further to this, we identified an additional, 
downstream gene (ecfY) that serves as a negative regulator of sigS expression by a novel 
mechanism of RNA-RNA mediated interaction.  In the absence of ecfY, S. aureus displays an 
increased resistance DNA damaging agents and components of the innate immune response, 
contrary to that which we have previously demonstrated for sigS mutants.   RNAseq analysis was 
performed on the ecfY null strain, as it is a sigS overexpression strain, in order to identify the σS 
regulon.  This analysis correlated tightly with previous work performed by our group on σS, 
demonstrating a role for it in the DNA-damage response, virulence, amino acid starvation and 
nucleotide biosynthesis (Burda et al., 2014), (Miller et al., 2012), (Shaw et al., 2008).  
Collectively, we demonstrate that the ECF-sigma factor in S. aureus, σS, is regulated via unique 
methods: positively thought the apparent need for an activator protein, and negatively via RNA-
RNA interaction. We contend that this adds unique knowledge, not only to our understanding of 
S. aureus regulatory circuits, but also to alternative sigma factor biology in general. 
 
  
! 86!
 
 
CHAPTER FOUR: 
ANTIBACTERIAL ACTIVITY OF A SERIES OF N2,N4-DISUBSTITUTED 
QUINAZOLINE-2,4-DIAMINES  
Note To Reader.   These results have been previously published (Burda et. al., 2014) with the 
permission of the publisher and the published manuscript can be found in Appendix 2. 
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CHAPTER FIVE: 
FINAL DISCUSSION 
Discussion.  ECF sigma factors are the largest and most diverse subfamily of σ70 enzymes, and 
typically respond to environmental stimuli (Helmann, 2002), (Llamas, Imperi, Visca, & Lamont, 
2014).  Indeed, many studies have demonstrated the importance of ECF sigma factors in the 
virulence of pathogens, such as P. aeruginosa, M. tuberculosis, and H. influenzae (Agarwal et 
al., 2007), (Bashyam & Hasnain, 2004), (Craig et al., 2002), (Llamas et al., 2014).  Our group 
has previously demonstrated the importance of the ECF sigma factor, σS, in the virulence of S. 
aureus using a murine model of septic arthritis (Shaw et al., 2008).  Curiously, we have also 
observed that sigS is differentially expressed among a variety of S. aureus lineages, which we 
hypothesized suggested a tight level of regulation.  
It is a hallmark of ECF sigma factors to be transcriptionally linked to a gene encoding a 
transmembrane anti-sigma factor that prevents the sigma factor from associating with core-
RNAP (Helmann, 1999), (Hughes & Mathee, 1998).  We demonstrate herein that the sigS locus 
is tightly conserved amongst the staphylococci, and consists only of σS, and three other genes. 
When looking at the down stream gene, ecfX, it does appear to be transcriptionally linked to sigS 
but does not contain any transmembrane domains.  With that said, cytoplasmic anti-sigma factors 
have been described, such as RsrA, which regulates the ECF sigma factor σR of S. coelicolor 
(Kang et al., 1999).  When we evaluated the effect of a mutation in ecfX, we unexpectedly 
observed a significant decrease in sigS expression, rather than the typical increase demonstrated 
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by anti-sigma factor inactivation in other organisms (Helmann, 1999), (Schurr et al., 1996).  
Curiously, we had previously noted that in an ancient staphylococcal species, S. carnosus, sigS 
and ecfX genes are annotated as a single open reading frame that encodes one protein.  Thus, we 
hypothesized that the sigS and ecfX genes arose as a single unit that has since diverged into two 
separate genes/proteins, but that may still function together.  In order to confirm this, we 
performed protein pull down assays with purified σS and EcfX and observed that these two 
proteins do in fact interact with each other.  These results suggest that σS and EcfX work together 
to bring about changes in gene expression in response to stress.  This is supported by the 
presence of a ComK domain in EcfX, which has been shown to bind to DNA and regulate gene 
expression. 
Downstream of ecfX in the conserved sigS locus is ecfY, which encodes a protein predicted to 
have 2 transmembrane domains; thus making it a more likely candidate to serve as an anti-sigma 
factor.  Interestingly, RNAseq analysis revealed that the majority of transcription in the sigS 
locus actually arises from an extended ecfY 3’ UTR that continues to run through ecfX and sigS.  
In order to determine if this is the reason for the low levels of sigS and ecfX expression we have 
previously observed (Miller et al., 2012), (Shaw et al., 2008), we performed northern blot 
analysis and confirmed our RNAseq results.  Therefore, we hypothesize that ecfY might regulate 
sigS and ecfX through this extended 3’ UTR, which is supported by qPCR analysis 
demonstrating an ecfY knock down strain has significantly increased sigS and ecfX expression.  
Classically, ECF sigma factors are regulated by a cognate anti-sigma factor through protein-
protein interaction; however, our findings suggest that ecfY is regulating sigS through RNA-RNA 
interaction via its extended 3’UTR.  In order to test our hypothesis, we constructed two ecfY 
complements strains that contain either the coding region of ecfY alone (ecfY-S), or the coding 
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region and the extended 3’ UTR (ecfY-L).  We observed that only when we complemented with 
the ecfY-L complement were we able to restore transcription of sigS to wild-type levels, 
indicating that it is the extended 3’UTR of ecfY, and not the EcfY protein that is responsible for 
the low level of expression of these two genes. 
When assessing the effect an ecfY mutation had on previously described sigS phenotypes, we 
found that they were opposing in nature.  Specifically, an ecfY null strain was more resistant to 
H2O2, MMS, ethidium bromide and UV irradiation when compared to both the wild-type and 
sigS mutant.  We attributed the increase in resistance to these DNA damaging agents to 
overexpression of sigS.  Again, we used our complementation constructs to explore these 
findings further, hypothesizing that if EcfY was regulating σS via protein-protein interaction, we 
would be able to complement our phenotypes with both complement constructs.  Conversely, if 
the regulation was occurring through RNA-RNA interaction, then we would only be able to 
complement our experiments with the ecfY coding region and extended 3’ UTR.  We determined 
that complementation of these phenotypes was only possible for the construct containing ecfY 
and the extended 3’ UTR, which again indicates that ecfY is regulating sigS through RNA-RNA 
interaction. 
Herein, we describe that ecfY is regulating sigS via RNA-RNA interaction, a phenomenon that 
has not been documented for ECF sigma factors, to date.  RNA-RNA mediated regulation has 
been described for the stationary phase sigma factor σS in E. coli (Hammerle et al., 2013), (Soper 
& Woodson, 2008).  The rpoS transcript, which encodes σS, forms a stem-loop secondary 
structure that sequesters the ribosomal binding sight and thereby inhibiting translation (Soper & 
Woodson, 2008).  At low temperatures, the small regulatory RNAs DsrA and RprA interact with 
the rpoS transcript to open this inhibitory stem-loop structure and facilitate translation (Brown & 
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Elliott, 1997), (Majdalani et al., 2001; Majdalani et al., 1998).  Conversely to that described for 
rpoS, in this present study we describe a situation where an extended 3’UTR is interacting with 
the transcript of sigS and ecfX to inhibit translation of these genes. 
In order to further explore the regulatory network modulating sigS expression, we also used a 
variety of approaches that include a biotin pull down assay, a forward and reverse transposon 
screen, and an NTG screen.  The results of these experiments support our previous studies of σS 
playing a role in amino acid, cell wall and nucleotide biosynthesis, and in the virulence of S. 
aureus (Miller et al., 2012), (Shaw et al., 2008).  In addition, our findings are further 
corroborated by RNAseq analysis performed on our ecfY null strain, which is essentially a sigS 
overexpressing strain. 
Our biotin pull down assay identified one transcriptional regulator, CymR that interacts with the 
promoter region of sigS.  Using qPCR, we demonstrated that there is an increase in sigS 
expression in the absence of cymR, indicating that it is a negative regulator of sigS. In order to 
validate the results of our biotin pull down assay, we performed electrophoretic mobility shift 
assays using purified CymR and observed that this protein does indeed bind to the promoter 
region of sigS. In S. aureus, CymR is the master regulator of cysteine biosynthesis and represses 
the transcription of 18 genes that are organized into 8 transcriptional units (Soutourina et al., 
2010; Soutourina et al., 2009).  Soutourina et. al. has demonstrated that a cymR mutant is more 
sensitive when exposed to hydrogen peroxide, which is a phenotype that we have also described 
for sigS (Miller et al., 2012), (Soutourina et al., 2010; Soutourina et al., 2009).  Interestingly, our 
RNAseq analysis of the ecfY null strain revealed a decrease in the expression of cymR, which 
might indicate a negative feed back loop, whereby σS may be involved in the transcription of a 
negative regulator of cymR in order to promote its own expression under stressful conditions.  In 
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addition, there is also a down regulation of several genes in the ecfY knock-down strain that have 
previously been shown to be directly regulated by CymR, such as the trx, cysK, cysM, ahpC, 
sodM and sodA.  We have previously shown that sigS expression is induced during oxidative 
stress, and sigS mutants are more sensitive to ROS, whereas our ecfY null strain is more resistant 
to this type of damage.  As such, these results indicate a reciprocal relationship of regulation 
likely exists between CymR and σS that strongly influences the response of S. aureus to ROS 
mediated stress.   
In connection with these findings, we identified alterations in expression of ahpC, which encodes 
an alkyl hydroperoxide reductase.  The AhpC enzyme is responsible for scavenging H2O2 in S. 
aureus and mutants that lack the ahpC gene have been shown to be more resistant when exposed 
to this agent (Cosgrove et al., 2007).  We observed a decrease in expression of this gene in the 
ecfY null strain, which would explain the increase in resistance an ecfY null strain when exposed 
to H2O2.  In addition, we observed increased expression of a putative cysteine and glutathione 
transporter, cydD, suggesting that σS may regulate genes that are involved in transporting these 
components from the environment.  Notably, glutathione and thioredoxin are cysteine-containing 
molecules that are important in the protection against oxidative stress (Carmel-Harel & Storz, 
2000), (Dickinson & Forman, 2002), (Gleason & Holmgren, 1988), (Masip, Veeravalli, & 
Georgiou, 2006), (Penninckx & Elskens, 1993), (Zeller & Klug, 2006).  In addition, there have 
been several studies that have demonstrated cysteine itself has a role in the ability of bacteria to 
sense oxidative stress (Lithgow, Hayhurst, Cohen, Aharonowitz, & Foster, 2004), (S. Park & 
Imlay, 2003).  Indeed, in the Gram-positive organism Lactobacillus reuteri, cysteine has been 
shown to protect the cell from H2O2 stress (Lo et al., 2009).  This suggests that σS mediated 
repression of cymR would lead to an increase in cysteine biosynthesis, which could be used to 
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sense oxidative stress, as well as being incorporated into enzymes that are involved in 
detoxification following ROS challenge. 
Our transposon assay to identify negative regulators, as well as our NTG screen, both revealed a 
mutation in lacR as having a strong influence on sigS expression.  In S. aureus, the lacR gene 
encodes the lactose operon repressor, which is responsible for negatively regulating the 
expression of genes involved in the transport and utilization of lactose (Oskouian & Stewart, 
1990).  Using qPCR analysis we confirmed that in absence of lacR there is an increase in the 
expression of sigS; however, EMSA analysis revealed that LacR is not a direct regulator.  In 
addition, our RNAseq analysis reveals a significant decrease in expression of lacR in the ecfY 
knock down strain.  These results would suggest that perhaps there is a negative feedback loop in 
which σS may be involved in the transcription of a negative regulator of lacR in order to promote 
its own expression under stressful conditions.  Further to this, previous exploration of the sigS 
regulon by our group suggests that this sigma factor is involved in regulating expression of lacA, 
lacB and lacD, as we demonstrate a decrease in expression of these genes in a sigS mutant 
(Miller, 2012). These results would suggest that sigS plays a role in the ability of S. aureus to 
utilize secondary carbon sources, such as lactose, and may also explain why our sigS mutant is 
unable to compete with the parent strain during starvation, as demonstrated by coculture analysis 
(Shaw et al., 2008).  Therefore, it is plausible that sigS plays a role overcoming starvation in S. 
aureus and that LacR indirectly represses expression of this sigma factor when it is grown under 
nutrient rich conditions. 
Preliminary work by our group suggests that σS plays a role in regulating genes that are involved 
in the de novo assembly of nucleotides (Miller, 2012).  The results of our transposon screen 
corroborate these findings as we identified that inactivation of the gene encoding the nucleoside 
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permease, nupC led to an increase in sigS expression.  NupC is hypothesized to be the primary 
pyrimidine transporter in S. aureus because of the high sequence similarity to NupC in B. subtilis 
(Kriegeskorte et al., 2014), (Saxild, Andersen, & Hammer, 1996).  In addition, Kriegeskorte et. 
al. demonstrated that a nupC mutant was unable to import extracellular thymidine into S. aureus  
(Kriegeskorte et al., 2014).  It would thus stand to reason that if cells were unable to import 
pyrimidines then they would have to synthesize them, and we have previously observed that sigS 
is involved in regulating genes that are involved in de novo nucleotide biosynthesis (Miller, 
2012).  Further to this, our RNAseq results reveal there to be an increase in the expression of 
genes involved in the de novo assembly of nucleotides, such as purC 
(phosphoribosylaminoimidazol-succinocarboxamide synthase), purH (bifunctional purine 
biosynthesis gene), purM (phosphoribosylformylglycinamidine clyclo-ligase), purN 
(phosphoriobylglycinamide formyltransferase), pyrH (bifunctional pyrimidine regulatory 
protein/uracil phosphoribosyltransferase) and tdk (thymidine kinase) in the ecfY knock-down 
strain.  We suggest that these findings may, at least in part, explain the sensitivity of sigS mutants 
(and resistance of ecfY mutants) to DNA damage, as previous studies have shown the vital 
importance of de novo nucleotide synthesis for surviving this type of stress (Valentino et al., 
2014), (Mei et al., 1997). Furthermore, recent studies have demonstrated that the de novo 
assembly of purines is vital to pathogenesis in S. aureus, E. coli, S. enterica, and B. anthracis 
(McFarland & Stocker, 1987), (Mei et al., 1997), (Samant et al., 2008), (Valentino et al., 2014). 
Therefore, it is plausible that the attenuation of virulence observed for sigS mutant strains may be 
due to depleted purine pools in vivo (Shaw et al., 2008). 
Our group has previously demonstrated a role for sigS in amino acid starvation, in that its 
expression is up regulated in amino acid limiting media (Miller et al., 2012).  Therefore, it is 
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unsurprising that we also identified insertions in a number of genes that are involved in amino 
acid biosynthesis.  The transposon screen used to identify negative regulators revealed that 
insertions in sucB, sucA, and ald led to an increase in sigS expression.  The genes sucA and sucB 
encode the 2-oxoglutarate system, while ald encodes alanine dehydrogenase.  The products of 
these three genes are responsible for converting amino acids into important intermediates in the 
tricarboxylic acid cycle (TCA), which in turn are used to create other amino acids and 
nucleotides.  Moreover, our transposon screen in which we induced expression of sigS using the 
DNA damaging agent MMS, also revealed a number of insertions in genes that are involved in 
amino acid biosynthesis.  These include the amino acid permease, potE, the large subunite of 
acetolactate synthase, ilvB, a branch chain amino acid transporter, brnQ3, and 
phosphoribosylanthranilate isomerase, trpF all of which lead to a decrease in the expression of 
sigS.  These results suggest that if cells are unable to synthesize and/or import amino acids, then 
S. aureus cannot upregulate sigS in order to over come amino acid starvation.  In connection with 
these findings, RNAseq analysis of the ecfY null strain revealed increased expression of genes 
that are involved amino acid biosynthesis such as argB (acetylglutamate kinase) and prs (ribose-
phosphate pyrophosphokinase).  Acetylglutamate kinase catalyzes the conversion of N-acetyl-L-
glutamate to N-acetyl-L-glutamate phosphate in the second step of arginine biosynthesis, which 
is then used to synthesize other amino acids, such as proline (Cunin et al., 1986), (Townsend et 
al., 1996).  Ribose-phosphate pyrophosphokinase is responsible for catalyzing the addition of a 
pyrophosphoryl group to ribose-5-phosphate.  The product of this reaction is phosphoribosyl 
diphosphate (PRPP), which is a key intermediate in the biosynthesis of amino acids, purines and 
pyrimidines (Hove-Jensen, 1985).  In B. subtilis, upregulation of prs leads to an increase in 
PRPP pools inside the cell, which in turn leads to an increase in free amino acids, and more 
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importantly, nucleotides (Zhu et al., 2015).  Our observation that prs is increased in an ecfY null 
strain may lead to such increase in PRPP, and explain why this strain is more resistant to DNA 
damage, while a sigS mutant is more sensitive. As such, this would appear to connect the 
upregulation of sigS in response to amino acids starvation, and the role of σS in de novo 
nucleotide biosynthesis. 
Our transposon screen also identified a mutation in the response regulator, arlR, which is 
involved in adhesion, autolysis and virulence, as producing an increase in sigS expression 
(Fournier & Hooper, 2000). Fournier et. al. previously demonstrated that when exposed to the 
detergent Triton X-100 an arlR mutant was more sensitive to killing, a phenotype that we have 
previously described for sigS mutants (Fournier & Hooper, 2000), (Shaw et al., 2008).  Liang et. 
al performed microarrary analysis and demonstrated that arlRS negatively regulates expression 
of the lacABCDEFG operon, which is negatively regulated by LacR, thus suggesting a 
connection between the influence of ArlR and LacR  on sigS expression (Liang et al., 2005).  
Further to this, it is plausible that the increase in expression of the lacABCDEFG operon in the 
absence of arlR is due to an increase in expression of sigS and thus σS mediated transcription of 
genes involved in the utilization of secondary carbon sources.  Liang et. al. also demonstrated 
that arlR negatively regulates ebh, another gene that was identified in our transposon screen as 
negatively influencing sigS expression (Liang et al., 2005).  The ebh gene encodes a large 
surface protein that is involved in adhesion and virulence.  Further to this, several studies have 
demonstrated that a lack of ebh leads to instability of the S. aureus cell wall (Cheng, Missiakas, 
& Schneewind, 2013), (Kuroda et al., 2001).  In addition, Cheng et. al. demonstrated that an ebh 
mutant is also more sensitive to killing by Triton-X100 and osmotic stress (Cheng et al., 2013).  
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Thus, these results could suggest that in the absence of alrR and ebh, sigS is upregulated in order 
to combat cell wall instability 
In our NTG screen we identified a mutation in the membrane sensor histidine kinase, kdpD that 
negatively influences sigS expression.  Interestingly, Liang et. al. also demonstrated that arlR 
negatively regulates expression of the two-component system, kdpDE (Liang et al., 2005).  The 
KdpDE system has been shown to be responsible for sensing and responding to potassium levels 
inside the cell and oxidative stress, as well as influencing virulence and intracellular survival 
(Chitnis, Freeman, Dorus, & Waterfield, 2013), (Xue et al., 2011).  KdpDE’s role in the 
intracellular survival has been linked to the regulation of genes involved in responding to 
oxidative stress, which we have previously demonstrated sigS to be involved in (Miller et al., 
2012).  Thus these results may indicate that during intracellular survival there is derepression of 
sigS by KdpE in order to combat oxidative damage caused by phagocytes.  In addition, this 
derepression is independent of arlR because this response regulator negatively regulates both 
sigS and kdpDE expression. 
We also identified mutations in two cell envelope associated genes in our transposon screen as 
having an increase in sigS expression, ebh, which we described above, and femB.  The femB gene 
forms an operon with femA and has been shown to be involved in peptidoglycan biosynthesis by 
the catalyzing the formation of the pentaglycine peptide bridge (Kopp, Roos, Wecke, & 
Labischinski, 1996).  This inability of femB mutants to properly assemble the cell wall leads to 
an increase in sensitivity to β-lactam antibiotics as demonstrated by Kopp et. al. (Kopp et al., 
1996).  Interestingly, our group has previously demonstrated that a sigS mutant is significantly 
more sensitive to the β-lactam antibiotics, ampicillin and penicillin-G.  In connection with this, 
RNAseq analysis of the ecfY null strain reveals an increase in expression of the gene mraY, 
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which encodes a phospho-N-acetylmuramoyl-pentapeptie-transferase that catalyzes the initial 
step in peptidoglycan biosynthesis.  In B. subtilis, overexpression of mraY leads to an increase in 
MIC for a number of cell wall targeting antibiotics (Ishizaki et al., 2013).  These results would 
suggest that σS is responsible for controlling expression of mraY in protecting S. aureus from 
damage to the cell wall.   
Conversely, we identified decrease in expression of atl, which encodes the major autolysin in S. 
aureus (Foster, 1995).  This autolysin is involved in cell wall turn over, contributing to the 
separation of daughter cells following cell division and in antibiotic induced lysis (Biswas et al., 
2006), (Foster, 1995), (Sugai et al., 1997).  We have previously demonstrated that sigS 
expression in induced following exposure to sodium dodecyl sulfate (SDS) and that sigS mutants 
are more susceptible to lysis by Triton X-100 (Miller et al., 2012).  These results suggest that σS 
may be responsible for the transcription of genes that are involved in cell wall biosynthesis in 
response to stress, while indirectly repressing the transcription of genes that are involved in 
degradation of the cell wall. 
Previous reports by our group have demonstrated that sigS expression is important in the 
virulence of S. aureus using both ex vivo and in vivo models of infection (Miller et al., 2012), 
(Shaw et al., 2008).  We describe here that an ecfY null strain is more resistant to phagocyte 
mediated killing when compared to the sigS mutant and wild-type strain, suggesting that sigS is 
responsible for controlling the expression of genes that are involved in virulence.  Along these 
lines, in the ecfY null strain we observed an increase in expression of the accessory gene 
regulator locus, agr, which encodes a two-component quorum sensing system important in 
virulence in S. aureus (Morfeldt et al., 1988), (Peng et al., 1988). Abdelnour, et al. demonstrated 
that agr is required for the establishment and development of septic arthritis in a murine model 
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of infection, which mirrors our own findings with sigS mutants in this same model (Abdelnour et 
al., 1993), (Shaw et al., 2008).  These results indicate that σS may be involved in controlling the 
expression of agr, and thus this may be the reason a sigS mutant is attenuated in virulence.  
Additionally, RNAseq analysis reveals an increase in expression of a fibronectin binding protein 
(SAUSA300_1101), which has been shown to be important in virulence.  Wesson et. al. has 
demonstrated that the ability of S. aureus to bind to host fibronectin greatly enhances the 
internalization of this bacterium in nonprofessional phagocytes (Wesson et al., 1998).  The 
ability of S. aureus to persist in nonprofessional phagocytes contributes to dissemination to other 
parts of the body, long term infection and resistance to antibiotics by hiding within host cells 
(Löffler, Tuchscherr, Niemann, & Peters, 2014).  Additionally, we observed an increase in 
expression of a fibrinogen binding protein, clumping factor B in the ecfY knock down strain.  
Previous studies have indicated that fibrinogen mediated adherences is crucial in virulence using 
a rabbit model of endocarditis (Moreillon et al., 1995).  These results suggest that σS may control 
the expression of genes that are crucial in adherence of S. aureus to host cells, therefore 
contributing to the internalization by nonprofessional phagocytes, perhaps leading to chronic 
infection. 
 
The success of S. aureus can, in part, be attributed to its ability to gain resistance to antibiotics.  
Since the introduction of antibiotics, resistance by S. aureus to newly deployed agents is 
commonly observed within 12 months (Davies, 2008).  Indeed, resistance to daptomycin 
emerged before the FDA had even approved the drug (America., 2004).  Vancomycin has 
traditionally been used as a mainstay against MRSA infections; however, recently there has 
emerged vancomycin-intermediate and vancomycin-resistant S. aureus (VISA and VRSA, 
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respectively).  With the rise in antibiotic resistance, it is becoming increasingly important to 
develop new antibacterial agents.  However, only seven new antibiotics were approved by the 
US Food and Drug Administration (FDA) in the last decade, none of which had a novel 
mechanism of action (Davies, 2008).  Thus, the development of novel antimicrobial compounds 
is a vital avenue of research in the fight against multi-drug resistant S. aureus. To this end, 
several studies have indicated the use of quinazolines as potent antimicrobial compounds.  
Quinazolines are an emerging class of compounds that have exhibited a number of 
pharmacological activities, such as sedative, analgesic, antimalarial, antihypertensive, 
antitumoral and antimicrobial (Bathini, Sidhu, Singh, Micetich, & Toogood, 2002), (Shiba, el-
Khamry, Shaban, & Atia, 1997). To this latter point, several studies have demonstrated that 
quinazolines are active against a wide range of bacterial organisms, including Bacillus subtilis, S. 
aureus, E. coli and P. aeruginosa (El-Gaby, 2000; Guan et al., 2005; He et al., 2012) (Mosaad, 
Mohammed, Ahmed, & Abdel-Hamide, 2004). In this study we present the characterization of a 
library of quinazolines by exploring their activity against multi-drug resistant S. aureus, their 
mechanism of action, likelihood of resistance and efficacy in vivo. 
In order to determine the effect of a library of quinazolines on multi-drug resistant S. aureus, we 
used a Kirby Bauer (KB) assay.  Using this method, we demonstrated that 53% of the library was 
active against our HA-MRSA strain.  While the KB assay has been a mainstay in determining 
antimicrobial susceptibility, it can be considered a qualitative assay, revealing very little about 
how potent many antimicrobial compounds are (El Feghaly, Stamm, Fritz, & Burnham, 2012).  
In order to quantitate the activity of our library, we determined the minimum inhibitory 
concentration (MIC), revealing that, while a number of compounds were active at very high 
concentrations, five had MICs ranging from 0.01 µg ml-1 to 3 µg ml-1.  Studies exploring the 
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antimicrobial activity of another series of quinazoline derivatives revealed high levels of activity 
against S. aureus with MICs of 6.25 µg ml-1, which is higher than the largest MIC we observed 
for our quinazoline derivatives, thus indicating that our quinazolines are more active than those 
currently described (Nosulenko et al., 2014). 
We next evaluated the minimum bactericidal concentration of our lead quinazoline compounds, 
and found that, whilst compounds 28, 32, 50 and 62 demonstrate varying degrees of bactericidal 
activity, compound 53 demonstrated bacteriostatic activity.  This is unusual as many derivatives 
of the same chemotype share the same activity as the parent compound; however, we 
demonstrate that compounds of the same class display not only varying degrees of bactericidal 
activity but also different activity all together.  This would indicate that these compounds are 
behaving in a manner that is unique compared to other currently available antibiotics.  The 
debate over whether it is more important for an antimicrobial compound to have bacteriostatic or 
bactericidal activity has been ongoing for many years (Finberg et al., 2004), (Pankey & Sabath, 
2004).  While bacteriostatic compounds are aided by the immune system when it comes to 
clearing an infection, it has been well documented that this is not the case for 
immunocompromised patients or patients inflicted with bacterial infections in the central nervous 
system or the heart (Finberg et al., 2004).  Therefore, in immunocompromised patients and those 
that are suffering from endocarditis and meningitis, the use of an antibiotic that possesses 
bactericidal activity are important in order to minimize the damage that may be caused due to 
infection (Finberg et al., 2004).   
An important attribute of antimicrobial compounds is their specificity for prokaryotic targets.  
Therefore, we determined the cytotoxicity of our lead quinazolines using adenocarcinoma human 
alveolar basal epithelial cells (A549).  For compounds 28, 32, 50 and 53 we demonstrated that at 
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all concentrations tested we recovered >50% of the A549 cells.  This suggests that our 
compounds are not cytotoxic to human cells and the killing effect these compounds have on S. 
aureus is specific.  However, for compound 62 we observed that as the concentration increased 
we recovered diminishing number of A549 cells.  These results are not surprising, as quinazoline 
derivatives have demonstrated to have potent activity against a number of human targets.  Yong 
et al. has demonstrated anti-cancer activity of quinazoline derivatives against A549 cells with an 
IC50 value of 4.26 µM (Yong, Lu, & Wu, 2015).  Additionally, studies indicate that quinazoline 
derivatives inhibit tyrosine kinases, which are important in regulating a number of physiological 
processes in both prokaryotes and eukaryotes (Grangeasse, Nessler, & Mijakovic, 2012), (Wilks, 
1990). 
S. aureus has the amazing ability to acquire resistance to antibiotics in a period of 6 to 12 
months, making treatment of infections caused by this pathogen very difficult.  The most 
common way a bacterium can acquire resistance is usually through the alteration of the target 
(Barker, 1999), which can be accomplished through mutating the gene that encodes it.  The rate 
at which this occurs is referred to as the mutation frequency (Martinez & Baquero, 2000).  Often 
the mutation frequency can be instrumental in determining the success of an antibiotic, with most 
currently approved agents falling in the range of 10-8 to 10-10 (Martinez & Baquero, 2000).  We 
evaluated the mutation frequency of our lead compounds and determined that resistance to 28, 
32, and 62 was easily acquired.  Conversely, for compounds 50 and 53 we observed mutation 
frequencies of less than 1 X 10-11 and 3.03 X 10-10, respectively.  These mutation frequencies are 
lower than those determined for other quinazoline derivatives, for example Huband et. al. has 
demonstrated that quinazoline-2, 4-dione derivatives have mutation frequencies of  3 X 10-7 
against S. aureus (Huband et al., 2007). 
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Next, we sought to identify the mechanism of action of our library of quinazoline 
compounds.  Because of the structural similarities of quinazoline and quinolones, we first 
sequenced the quinolone resistant determining regions (QRDR) of our spontaneous mutants. 
Quinolones interfere with the ability of a cell to unwind or coil its DNA, which is essential in 
DNA replication (Deitz, Cook, & Goss, 1966).  Huband et. al. has demonstrated that a series of 
quinazoline-2,4-diones are gyrase and topoisomerase inhibitors and are active against a large 
number of pathogens including S. aureus, Listeria monocytogenes, and Legionella pneumoniae 
(Huband et al., 2007).  When we sequenced the QRDR, we did not observe any mutation in these 
regions of our spontaneous mutants compared to the wild-type, thus indicating that our 
quinazoline derivatives are not gyrase or topoisomerase inhibitors.  Several studies have 
indicated that quinazolines inhibit the enzyme dihydrofolate reductase (DHFR), which catalyzes 
the conversion of dihydrofolate into tetrahydrofolate (THF) in the final step in folic acid 
production, an essential process in bacteria (Bermingham & Derrick, 2002), (Blaney, Hansch, 
Silipo, & Vittoria, 1984), (Ghose & Crippen, 1982).  We sequenced the DHFR locus of our 
spontaneous mutants and the wild-type strain in order to determine if these compounds inhibit 
this enzyme.  Upon analysis, we did not find any mutations in this locus in our mutant strains 
compared to the wild-type, which would indicate that this is not the mechanism of action.  
However, Van Horn et. al. previously characterized a series of quinazolines against the 
eukaryote L. donovani that inhibit dihydropteroate synthase (DHPS).  They observed that the 
addition of exogenous para-aminobenzoic acid, which is a substrate of DHPS and essential in 
folic acid production, rescued quinazoline-mediated killing of L. donovani (Van Horn et al., 
2014).  Therefore, we hypothesized that if our quinazoline derivatives inhibit DHFR than the 
addition of the end product THF should rescue S. aureus from quinazoline-mediated killing.  
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Upon analysis, we observed that addition of exogenous THF to cells grown in the presence of a 
lethal concentration of compounds 32, 50, 53, and 62 rescued the growth of S. aureus, even at 
the lowest concentration of THF tested.  These results were comparable with the known DHFR 
inhibitor, trimethoprim, suggesting that these quinazolines are interfering with folic acid 
production in S. aureus.  This contrasts somewhat with the lack of mutations in the DHFR gene 
for resistant strains, however it might be that the mechanism of resistance to these compounds is 
mediated via efflux pumps; possibly via their overexpression.  Indeed, S. aureus’ resistance to a 
number of antibiotics, such as fluoroquinolones, tetracycline, and novobiocin, is mediated 
through the use of such pumps (Costa, Viveiros, Amaral, & Couto, 2013).  
The known DHFR inhibitor, trimethoprim, is always used in conjunction with another antibiotic 
that targets the folic acid biosynthesis, sulfamethoxazole.  This is because when trimethoprim 
and sulfamethoxazole are used together they are synergistic, meaning together they are able to 
achieve bacterial killing at lower MICs than each one individually.  In addition, these two 
compounds act at two separate steps in the biosynthesis of folate and create a toxic intermediate 
(Gleckman, Alvarez, & Joubert, 1979).  In regard to our library of quinazolines, because the 
mechanism of action of these antimicrobials is through the inhibition of DHFR we were curious 
to determine if they were synergistic with sulfamethoxazole.  Therefore, we determined the 
fractional inhibitory concentration (R. Manganelli et al.) of lead compounds and 
sulfamethoxazole individually and in combination.  The FIC was then used to calculate the 
ΣFIC, demonstrating that our quinazoline derivatives act synergistic with sulfamethoxazole as 
demonstrated by ΣFICs that are below the ≤ 0.5 threshold used to define synergism of two 
agents. 
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The major goal of this study was to identify novel antimicrobials that were efficacious in vivo.  
Therefore, we first evaluated efficacy using a Galleria mellonella model of infection.  We 
observed a significant increase in survival of G. mellonella treated with either 5X or 10X the 
MIC of our quinazolines, when compared to those that were untreated.  Following this, we 
assessed the efficacy of our lead quinazolines using an in vivo model of murine peritonitis.  In so 
doing we observed increased survival of mice that were treated with either compound 50 or 53 
compared to those that were treated with the negative control. Further more, we observed an 
increase in survival of mice that were treated with our quinazolines relative to those that were 
treated with the positive control, vancomycin, thus indicating that our compounds are more 
efficacious in vivo than the last line of defense antibiotic against multi-drug resistant S. aureus.  
Thus, the results of our study demonstrate the potential of N2, N4-disubstituted quinazoline-2, 4-
diamines as an effective treatment option against infections caused by MRSA. 
 
Future Directions.  In this study, we demonstrate that the expression of sigS is influenced by a 
number of different elements that are involved in the DNA damage response, and amino acid and 
cell wall biosynthesis.  Specifically, we identified that CymR and KdpE bind to the sigS 
promoter and represses transcription.  Future work investigating the genetic regulation of sigS 
will focus on exploring the relationship between these direct regulators and sigS.  In order to do 
this, we will construct a sigS cymR double mutant and evaluate this strains ability to survive 
when exposed to chemical stressors that result in oxidative damage, as both sigS and cymR have 
been shown to play a role in this type of stress (Miller et al., 2012), (Soutourina et al., 2010; 
Soutourina et al., 2009).  In addition, Soutourina et. al. has previously demonstrated that a cymR 
mutant is better able to survive intracellularly after phagocytosis by RAW 264.7 cells, therefore, 
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we hypothesize that this may result from increased sigS expression.  In order to determine if this 
is true, we will evaluate the ability of the sigS cymR double mutant to survive post-phagocytosis 
when compared to the wild-type, a sigS mutant, and a cymR mutant.  We expect that a sigS cymR 
double mutant will display the same phenotype as a sigS mutant.  
Also, our study reveals that sigS is regulated in a unique manner: positively by EcfX and 
negatively by ecfY, through RNA-RNA mediated interaction.  Therefore, future work regarding 
this unique event will include investigating the interaction between σS and EcfX.  Because σS is a 
sigma factor and is required to associate with core-RNAP in order to function, we aim to 
determine if EcfX can also associate with the RNAP complex.  This will be performed using 
nickel bead pull down assays, and various combinations of purified proteins.  These assays will 
be performed using EcfX with core-RNAP, σS and core-RNAP, EcfX and σS, core-RNAP by 
itself, σS by itself and EcfX by itself.  Our group has also previously demonstrated that σS is able 
to bind to core-RNAP and initiate transcription from its own promoter (Shaw et al., 2008).  
Therefore, in order to elucidate the involvement of EcfX in the initiation process we will perform 
transcriptional run off experiments.  These assays will be undertaken using EcfX with core-
RNAP, σS and core-RNAP, EcfX and σS, core-RNAP by itself, σS by itself and EcfX by itself.  
We will perform these assays with the promoter region of sigS, as we know that it can bind with 
RNAP and initiate transcription from its own promoter.   
In this present study, we provide evidence suggesting that ecfY is regulating sigS expression 
through RNA-RNA interaction of the extended 3’ end of ecfY that is antisense to the transcript of 
sigS.  Therefore, future work would include demonstrating interaction between the ecfY and sigS 
transcripts through enzymatic and chemical approaches.  In the event that the extended 3’ end of 
ecfY binds to the sigS transcript, it would be interesting to evaluate if an RNase has a role in 
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degrading this double stranded RNA complex.  This can be achieved by evaluating expression of 
sigS in a mutant that lacks the rnc gene, which encodes the major RNase (RNaseIII) in S. aureus, 
and comparing expression to the ecfY null strain and the wild-type.  In addition, we would like to 
evaluate the contribution ecfY makes to the pathogenesis of S. aureus using a murine model of 
sepsis.  In the present study, we demonstrated that an ecfY mutant is more resistant when 
challenged with components of the innate immune response, while a sigS mutant is more 
sensitive.  We have previously demonstrated that a sigS mutant is attenuated in virulence using a 
murine model of septic arthritis; therefore, our results suggest that an ecfY null strain would be 
hypervirulent.  Additionally, the results from our RNAseq analysis will be confirmed in context 
of both sigS and ecfY.  In order to confirm these results and to determine if it is due to the over 
expression of sigS or a lack of ecfY, qPCR analysis will be performed on the wild-type strain, the 
ecfY mutant, and the ecfY-S and ecfY-L complement strains.  Moreover, for any genes determined 
to be regulated by σS, we will also evaluate the impact that EcfX has on the expression of these 
genes.  In addition, we will use a combination of bioinformatic and DNA foot printing 
approaches to identify a consensus sequence for σS using genes that are determined to be 
regulated by this sigma factor. 
Future works regarding our quinazolines include assessing the in vivo efficacy of these drugs in 
combination with sulfamethoxazole using murine systems. In addition, we aim to elucidate the 
pharmacokinetic and pharmacodynamics properties of our quinazoline compounds.  With 
regards to the pharmacokinetics, we will explore the absorption of our compounds, which 
includes the bioavailability, distribution and elimination of the drugs.  In addition, we will also 
determine the area under the curve for serum concentration, and peak serum and trough levels of 
the compounds in plasma and tissue of mice that have been exposed to our drugs.  With regards 
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to the pharmacodynamics of our compounds, we will determine the in vivo half-life and the 
therapeutic window of our drugs.  We have demonstrated in our study that these compounds 
appear to inhibit DHFR; therefore, computer modeling will be performed in order to determine 
how our quinazoline compounds bind to and inhibit DHFR.  In addition, any information gained 
from the computer modeling will be confirmed using purified DHFR and quinazolines in tandem 
with X-ray crystallography. 
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